Document:

EX-10.8

 Exhibit 10.8 

RUSH STREET INTERACTIVE, INC. 2020 OMNIBUS EQUITY INCENTIVE PLAN 

1. Purpose; Eligibility. 

1.1 General Purpose. The name of this plan is the Rush Street Interactive, Inc., 2020 Omnibus Equity Incentive Plan. The purpose of the
Plan is to (a) enable Rush Street Interactive, Inc., a Delaware corporation (the “Company”), and any Affiliate to attract and retain the types of Employees, Consultants, and Independent Directors who will contribute to the
Company’s long range success; (b) provide incentives that align the interests of Employees, Consultants and Independent Directors with those of the stockholders of the Company; and (c) promote the success of the Company’s
business. 
 1.2 Eligible Award Recipients. The Persons eligible to receive Awards are the Employees, Consultants and Independent
Directors of the Company and its Affiliates and such other individuals designated by the Committee who are reasonably expected to become Employees, Consultants and Independent Directors after the receipt of Awards. 

1.3 Available Awards. Awards that may be granted under the Plan include: (a) Incentive Stock Options, (b) Non-qualified Stock Options, (c) Stock Appreciation Rights, (d) Restricted Awards, (e) Performance Share Awards, (f) Cash Awards, and (g) Other Equity-Based Awards. 

2. Definitions. For purposes of the Plan, the following terms shall be defined as set forth below: 

“Affiliate” means a parent or subsidiary corporation of the Company, as defined in Section 424 of the Code (substituting
“Company” for “employer corporation”), any other entity that is a parent or subsidiary of the Company, including a parent or subsidiary which becomes such after the Effective Date of the Plan. 

“Applicable Laws” means the requirements related to or implicated by the administration of the Plan under applicable state
corporate law, United States federal and state securities laws, the Code, any stock exchange or quotation system on which the shares of Common Stock are listed or quoted, and the applicable laws of any foreign country or jurisdiction where Awards
are granted under the Plan. 
 “Award” means any right granted under the Plan, including an Incentive Stock Option, a Non-qualified Stock Option, a Stock Appreciation Right, a Restricted Award, a Performance Share Award, a Cash Award, or an Other Equity-Based Award. 

“Award Agreement” means a written agreement, contract, certificate or other instrument or document evidencing the terms and
conditions of an individual Award granted under the Plan which may, in the discretion of the Company, be transmitted electronically to any Participant. Each Award Agreement shall be subject to the terms and conditions of the Plan. 

 “Beneficial Owner” has the meaning assigned to such term in Rule 13d-3 and Rule 13d-5 under the Exchange Act, except that in calculating the beneficial ownership of any particular Person, such Person shall be deemed to have beneficial
ownership of all securities that such Person has the right to acquire by conversion or exercise of other securities, whether such right is currently exercisable or is exercisable only after the passage of time. The terms “Beneficially
Owns,” “Beneficially Owned” and “Beneficial Ownership” have a corresponding meaning. 
 “Board”
means the Board of Directors of the Company, as constituted at any time. 
 “Cash Award” means an Award denominated in cash
that is granted under Section 10 of the Plan. 
 “Cause” means: 

(a) With respect to any Employee or Consultant, unless the applicable Award Agreement provides otherwise, if the Employee or Consultant is a
party to an employment or service agreement with the Company or its Affiliates and such agreement provides for a definition of Cause (or any term of similar effect), the definition contained therein; or if no such agreement exists, or if such
agreement does not define Cause (or any term of similar effect): (i) the commission of, or plea of guilty or no contest to, a felony or other crime involving dishonesty, moral turpitude or the commission of any other act involving willful
malfeasance or breach of fiduciary duty with respect to the Company or an Affiliate; (ii) any acts, omissions or statements that the Company determines to be detrimental or damaging to the reputation, operations, prospects or business relations
of the Company or an Affiliate; (iii) negligence or willful misconduct with respect to the Company or an Affiliate, or willful or repeated failure or refusal to substantially perform assigned duties; (iv) violation of state or federal
securities laws; (v) violation of the Company’s written policies or codes of conduct, including written policies related to discrimination, harassment, performance of illegal or unethical activities, and ethical misconduct; (vi) any
act of fraud, embezzlement, material misappropriation or dishonesty against the Company or an Affiliate; (vii) any material breach of a written agreement with the Company or an Affiliate, including, without limitation, a breach of any
employment, consulting, confidentiality, non-competition, non-solicitation, non-disparagement or similar agreement. 

(b) With respect to any Independent Director, unless the applicable Award Agreement provides otherwise, a determination by a majority of the
disinterested Board members that the Independent Director has engaged in any of the following: (i) malfeasance in office; (ii) gross misconduct or negligence; (iii) false or fraudulent misrepresentation inducing the Independent
Director’s appointment; (iv) willful conversion of corporate funds; or (v) repeated failure to participate in Board meetings on a regular basis despite having received proper notice of the meetings in advance. 

The Committee, in its absolute discretion, shall determine the effect of all matters and questions relating to whether a Participant has been
discharged for Cause. 
 “Change in Control” means, except as otherwise provided in an Award Agreement, the occurrence of
any of the following events after the Effective Date: 
 (a) A transaction or series of transactions (other than an offering of shares of
Common Stock to the general public through a registration statement filed with the Securities and Exchange Commission or a transaction or series of transactions that meets the requirements of clauses (i) and (ii) of subsection (d) below)
whereby any Person (other than any Seller (or any 

  
 2 

 
Seller’s Family Members and/or Affiliates) the Company, any of its Subsidiaries, an employee benefit plan maintained by the Company or any of its Subsidiaries or a Person that, prior to such
transaction, directly or indirectly controls, is controlled by, or is under common control with, the Company) directly or indirectly acquires Beneficial Ownership of securities of the Company possessing more than 50% of the total combined voting
power of the Company’s securities outstanding immediately after such acquisition; 
 (b) During any period of 24 months, individuals
who, at the beginning of such period, constitute the Board (the “Incumbent Directors”) cease for any reason to constitute at least a majority of the Board; provided, that any Person becoming a Director subsequent to the
Effective Date, whose election or nomination for election was approved by a vote of at least two-thirds of the Incumbent Directors then on the Board (either by a specific vote or by approval of the proxy
statement of the Company in which such Person is named as a nominee for Director, without written objection to such nomination) shall be an Incumbent Director; provided, however, that no individual initially elected or nominated as a
Director during such period as a result of an actual or threatened election contest, as such terms are used in Rule 14a-12 of Regulation 14A promulgated under the Exchange Act, with respect to Directors or as
a result of any other actual or threatened solicitation of proxies or consents by or on behalf of any Person other than the Board shall be deemed to be an Incumbent Director; or 

(c) The date that is ten (10) business days prior to the complete liquidation or dissolution of the Company; or 

(d) The consummation by the Company (whether directly involving the Company or indirectly involving the Company through one or more
intermediaries) of (x) a merger, consolidation, reorganization, or business combination or (y) a sale or other disposition of all or substantially all of the Company’s assets in any single transaction or series of related transactions
or (z) the acquisition of assets or shares of another entity, in each case other than a transaction: 
 (i) which results in the
Company’s voting securities outstanding immediately before the transaction continuing to represent (either by remaining outstanding or by being converted into voting securities of the Company or the Person that, as a result of the transaction,
controls, directly or indirectly, the Company or owns, directly or indirectly, all or substantially all of the Company’s assets or otherwise succeeds to the business of the Company (the Company or such Person, the “Successor
Entity”)) directly or indirectly, at least a majority of the combined voting power of the Successor Entity’s outstanding voting securities immediately after the transaction, and 

(ii) after which no Person beneficially owns voting securities representing 50% or more of the combined voting power of the Successor Entity;
provided, however, that no Person shall be treated for purposes of this clause (ii) as beneficially owning 50% or more of the combined voting power of the Successor Entity solely as a result of the voting power held in the Company
prior to the consummation of the transaction. 

  
 3 

 Notwithstanding the foregoing, if a Change in Control constitutes a payment event with
respect to any Award (or portion of any Award) that provides for the deferral of compensation that is subject to Section 409A, to the extent required to avoid the imposition of additional taxes under Section 409A, the transaction or event
described in subsection (a), (b), (c) or (d) with respect to such Award (or portion thereof) shall only constitute a Change in Control for purposes of the payment timing of such Award if such transaction also constitutes a “change in
control event,” as defined in Treasury Regulation Section 1.409A-3(i)(5). 
 For the
avoidance of doubt and notwithstanding anything to the contrary contained here, a Change in Control shall not be deemed to have occurred if Sellers, their Family Members and any of their respective Affiliates directly or indirectly own (individually
or in the aggregate) more than 50% of the voting securities of the Company (or any successor to all or substantially all the assets of the Company and its Subsidiaries) or any direct or indirect parent company. 

The Committee shall have full and final authority, which shall be exercised in its discretion, to determine conclusively whether a Change in
Control has occurred pursuant to the above definition, the date of the occurrence of such Change in Control and any incidental matters relating thereto; provided that any exercise of authority in conjunction with a determination of whether a Change
in Control is a “change in control event” as defined in Treasury Regulation Section 1.409A-3(i)(5) shall be consistent with such regulation. 

“Code” means the Internal Revenue Code of 1986, as it may be amended from time to time. Any reference to a section of the
Code shall be deemed to include a reference to any regulations promulgated thereunder. 
 “Committee” means the
Compensation Committee of the Board or one or more subcommittees appointed by the Committee to administer the Plan in accordance with Section 3.3 and Section 3.4 or, if no such Compensation Committee or subcommittee thereof exists, or in
its sole discretion, the Board. 
 “Common Stock” means the Class A common stock, $0.0001 par value per share, of the
Company, or such other securities of the Company as may be designated by the Committee from time to time in substitution thereof. 

“Company” means Rush Street Interactive, Inc., a Delaware corporation, and any successor thereto. 

“Consultant” means any individual or entity which performs bona fide services for the Company or an Affiliate, other than as
an Employee or Independent Director, and who may be offered securities registerable pursuant to a registration statement on Form S-8 under the Securities Act. 

“Continuous Service” means that the Participant’s service with the Company or an Affiliate, whether as an Employee,
Consultant or Independent Director, is not interrupted or terminated. The Participant’s Continuous Service shall not be deemed to have terminated merely because of a change in the capacity in which the Participant renders service to the Company
or an Affiliate as an Employee, Consultant or Independent Director or a change in the entity for which the Participant renders such service, provided that there is no interruption or termination of the Participant’s Continuous Service;
provided further that if any Award is subject to Section 409A of the Code, this sentence shall only be given effect to the extent consistent with Section 409A of the Code. For example, a change in status from an Employee of the
Company to an Independent 

  
 4 

 
Director of an Affiliate will not constitute an interruption of Continuous Service. The Committee or its delegate, in its sole discretion, may determine whether Continuous Service shall be
considered interrupted in the case of any leave of absence approved by that party, including sick leave, military leave or any other personal or family leave of absence. The Committee or its delegate, in its sole discretion, may determine whether a
Company transaction, such as a sale or spin-off of a division or subsidiary that employs a Participant, shall be deemed to result in a termination of Continuous Service for purposes of affected Awards, and any
such decision shall be final, conclusive and binding on all parties. 
 “Deferred Stock Units” has the meaning set forth in
Section 8.1(b) hereof. 
 “Director” means a member of the Board. 

“Disability” means, unless the applicable Award Agreement provides otherwise, that the Participant is unable to engage in any
substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected to last for a continuous period of not less than 12 months. The
determination of whether an individual has a Disability shall be determined under procedures established by the Committee. Except in situations where the Committee is determining Disability for purposes of the term of an Incentive Stock Option
pursuant to Section 6.9 hereof within the meaning of Section 22(e)(3) of the Code, the Committee may rely on any determination that a Participant is disabled for purposes of benefits under any long-term disability plan maintained by the
Company or any Affiliate in which a Participant participates. 
 “Disqualifying Disposition” has the meaning set forth in
Section 16.11. 
 “Effective Date” shall mean the later of (i) the date that the Company’s stockholders
approve the Plan and (ii) December 29, 2020. 
 “Eligible Person” means any individual who, as of the date of
grant of an Award, is an Employee, Consultant or Independent Director; provided, however, that, any such individual must be an “employee” of the Company or any of its parents or subsidiaries within the meaning of General Instruction
A.1(a) to Form S-8 if such individual is granted an Award that may be settled in Common Stock. An employee on leave of absence may be an Eligible Person. 

“Employee” means any Person, including an Officer or Director who is not an Independent Director employed by the Company or
an Affiliate; provided, that, for purposes of determining eligibility to receive Incentive Stock Options, an Employee shall mean an employee of the Company or a parent or subsidiary corporation within the meaning of
Section 424 of the Code. Mere service as an Independent Director or payment of a director’s fee by the Company or an Affiliate shall not be sufficient to constitute “employment” by the Company or an Affiliate. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended. 

  
 5 

 “Fair Market Value” means, with respect to a share of Common Stock as of a
given date of determination hereunder, the closing price as quoted on the New York Stock Exchange or on such other principal exchange or market on which the Common Stock is traded on such date of determination, or if the Common Stock was not traded
on such date, then the immediately preceding date on which sales of shares of Common Stock have been so quoted or reported shall be used. If there should not be a public market for the Common Stock on such date, “Fair Market Value” shall
be such value as determined by the Board in its discretion and, to the extent necessary, shall be determined in a manner consistent with Section 409A of the Code. Any such determination by the Board shall be final, conclusive, and binding on
all parties. 
 “Fiscal Year” means the Company’s fiscal year. 

“Family Member” means (a) (i) each of Neil Bluhm, Greg Carlin, Richard Schwartz, Einar Roosileht and Mattias Stetz (each
an “Executive”), (ii) the spouse and lineal descendants (whether natural or adopted) of any Executive, (iii) any spouse of any of the individuals described in clause (ii), and (iv) a trust solely for the benefit of
any individuals described in the foregoing clauses (i) through (iii); and (b) any siblings or parents of any of the individuals described in clause (a)(i) through (iii). 

“Free Standing Rights” has the meaning set forth in Section 7. 

“Grant Date” means the date on which the Committee adopts a resolution, or takes other appropriate action, expressly granting
an Award to a Participant that specifies the key terms and conditions of the Award or, if a later date is set forth in such resolution, then such date as is set forth in such resolution. 

“Incentive Stock Option” means an Option that is designated by the Committee as an incentive stock option within the meaning
of Section 422 of the Code and that meets the requirements set out in the Plan. 
 “Independent Director” means any
member of the Board or any member of the board of directors of an Affiliate (or similar governing body of an Affiliate that is not a corporation) who is not an Employee or Consultant. 

“Non-Employee Director” means a Director who is a
“non-employee director” within the meaning of Rule 16b-3. 

“Non-qualified Stock Option” means an Option that by its terms does not qualify or is
not intended to qualify as an Incentive Stock Option. 
 “Officer” means a Person who is an officer of the Company within
the meaning of Section 16 of the Exchange Act and the rules and regulations promulgated thereunder. 
 “Option” means
a right, granted to an Eligible Person under Section 6, to purchase Common Stock at a specified price during specified time periods, which may either be an Incentive Stock Option or a Non-qualified Stock
Option granted pursuant to the Plan. 
 “Optionholder” means an Eligible Person to whom an Option is granted pursuant to
the Plan or, if applicable, such other Person who holds an outstanding Option. 
 “Option Exercise Price” means the price
at which a share of Common Stock may be purchased upon the exercise of an Option. 

  
 6 

 “Other Equity-Based Award” means an Award that is not an Option, Stock
Appreciation Right, Restricted Stock, Restricted Stock Unit, or Performance Share Award that is granted to an Eligible Person under Section 10 and is payable by delivery of Common Stock and/or which is measured by reference to the value of
Common Stock. 
 “Participant” means an Eligible Person to whom an Award is granted pursuant to the Plan or, if applicable,
such other Person who holds an outstanding Award. 
 “Performance Criteria” means the criterion or criteria that the
Committee shall select for purposes of establishing the Performance Goal(s) for a Performance Period with respect to any Award under the Plan. The Performance Criteria that will be used to establish the Performance Goal(s) shall be based on the
attainment of specific levels of performance of the Company (or Affiliate, division, business unit or operational unit of the Company) or any Participant, which may be determined in accordance with GAAP or on a
non-GAAP basis including, but not limited to, one or more of the following measures: (a) terms relative to a peer group or index; (b) basic, diluted, or adjusted earnings per share; (c) sales or
revenue;(d) earnings before interest, taxes, and other adjustments (in total or on a per share basis); (e) cash available for distribution; (f) basic or adjusted net income; (g) returns on equity, assets, capital, revenue or similar
measure; (h) level and growth of dividends; (i) the price or increase in price of Common Stock; (j) total shareholder return; (k) total assets; (l) growth in assets, new originations of assets, or financing of assets;
(m) equity market capitalization; (n) reduction or other quantifiable goal with respect to general and/or specific expenses; (o) equity capital raised; (p) mergers, acquisitions, increase in enterprise value of Affiliates,
Subsidiaries, divisions or business units or sales of assets of Affiliates, Subsidiaries, divisions or business units or sales of assets; and (q) any combination of the foregoing. Any one or more of the Performance Criteria may be stated as a
percentage of another Performance Criteria, or used on an absolute or relative basis to measure the performance of the Company and/or one or more Affiliates as a whole or any divisions or operational and/or business units, business segments,
administrative departments of the Company and/or one or more Affiliates or any combination thereof, as the Committee may deem appropriate, or any of the above Performance Criteria may be compared to the performance of a selected group of comparison
companies, or a published or special index that the Committee, in its sole discretion, deems appropriate, or as compared to various stock market indices. 

“Performance Goals” means, for a Performance Period, the one or more goals established by the Committee for the Performance
Period based upon Performance Criteria determined by the Committee in its discretion. 
 “Performance Period” means the one
or more periods of time, as the Committee may select, over which the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant’s right to and the payment of a Performance Share Award or a Cash
Award. 
 “Performance Share Award” means any Award granted pursuant to Section 9 hereof. 

  
 7 

 “Performance Share” means the grant of a right to receive a number of
actual shares of Common Stock or share units based upon the performance of the Company during a Performance Period, as determined by the Committee. 

“Permitted Transferee” means: (a) a member of the Participant’s immediate family (child, stepchild, grandchild,
parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law,
father-in-law, son-in-law, daughter-in-law, brother-in-law, or
sister-in-law, including adoptive relationships), a trust in which these Persons have more than 50% of the beneficial interest, a foundation in which these Persons (or
the Participant) control the management of assets, and any other entity in which these Persons (or the Participant) own more than 50% of the voting interests; and (b) such other transferees as may be permitted by the Committee in its sole
discretion. 
 “Person” means an individual, entity or group (within the meaning of Section 13(d)(3) of the Exchange
Act). 
 “Plan” means this Rush Street Interactive, Inc. 2020 Omnibus Equity Incentive Plan, as it may be amended from time
to time. 
 “Related Rights” has the meaning set forth in Section 7. 

“Restricted Award” means any Award granted pursuant to Section 8. 

“Restricted Period” has the meaning set forth in Section 8. 

“Rule 16b-3” means Rule 16b-3 promulgated
under the Exchange Act or any successor to Rule 16b-3, as in effect from time to time. 

“Securities Act” means the Securities Act of 1933, as amended. 

“Sponsor” means dMY Sponsor, LLC, a Delaware limited liability company. 

“Stock Appreciation Right” means the right pursuant to an Award granted to an Eligible Person under Section 7 to
receive, upon exercise, an amount payable in cash or shares equal to the number of shares subject to the Stock Appreciation Right that is being exercised multiplied by the excess of (a) the Fair Market Value of a share of Common Stock on the
date the Award is exercised, over (b) the exercise price specified in the Stock Appreciation Right Award Agreement. 
 “Stock
for Stock Exchange” has the meaning set forth in Section 6.4. 
 “Subsidiary” means any entity (other than
the Company), whether domestic or foreign, in an unbroken chain of entities beginning with the Company if each of the entities other than the last entity in the unbroken chain beneficially owns, at the time of the determination, securities or
interests representing at least 50% of the total combined voting power of all classes of securities or interests in one of the other entities in such chain. 

“Substitute Award” has the meaning set forth in Section 4.5. 

  
 8 

 “Ten Percent Stockholder” means a Person who owns (or is deemed to own
pursuant to Section 424(d) of the Code) stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or of any of its Affiliates. 

“Total Share Reserve” has the meaning set forth in Section 4.1. 

3. Administration. 
 3.1
Authority of Committee. The Plan shall be administered by the Committee. Subject to the terms of the Plan, any restrictions on the authority delegated to it by the Board, and Applicable Laws, and in addition to other express powers and
authorization conferred by the Plan, the Committee shall have the authority to: 
 (a) designate Eligible Persons as Participants; 

(b) determine the type or types of Awards to be granted to an Eligible Person; 

(c) determine the number of shares of Common Stock or amount of cash to be covered by Awards; 

(d) authorize any Person to execute, on behalf of the Company, any instrument required to carry out the purposes of the Plan; 

(e) determine the terms and conditions of any Award, including whether, to what extent and under what circumstances Awards may be vested,
settled, exercised, cancelled or forfeited (including conditions based on Continuous Service or the achievement of one or more Performance Goals); 

(f) modify, waive or adjust any term or condition of an Award that has been granted, which may include the acceleration of vesting, waiver of
forfeiture restrictions, modification of the form of settlement of the Award (for example, from cash to Common Stock or vice versa), early termination of a Performance Period, or modification of any other condition or limitation regarding an Award;

 (g) determine the treatment of an Award upon a termination of employment or other service relationship; 

(h) impose a holding period with respect to an Award or the shares of Common Stock received in connection with an Award; 

(i) impose a “blackout” or other periods during which Awards may not be exercised or settled; 

(j) construe, interpret and administer the Plan and any Award Agreement; 

  
 9 

 (k) promulgate, amend, and rescind rules and regulations relating to the administration of
the Plan; 
 (l) correct any defect, supply any omission or reconcile any inconsistency in the Plan, in any Award, or in any Award
Agreement; and 
 (m) make any other determination and take any other action that the Committee deems necessary or desirable for the
administration of the Plan. 
 The express grant of any specific power to the Committee, and the taking of any action by the Committee,
shall not be construed as limiting any power or authority of the Committee. 
 3.2 Committee Decisions Final. All decisions made by
the Committee pursuant to the provisions of the Plan shall be final, conclusive, and binding on the Company and the Participants, unless such decisions are determined by a court having jurisdiction to be arbitrary and capricious. 

3.3 Delegation. The Committee may delegate administration of the Plan to a subcommittee or subcommittees of one or more members of the
Board, and the term “Committee” shall apply to any Person or Persons to whom such authority has been delegated, provided, that such delegation does not (i) violate Applicable Laws or (ii) result in the loss of an
exemption under Rule 16b-3(d)(1) for Awards granted to Participants subject to Section 16 of the Exchange Act in respect of the Company. Any such delegation may be revoked by the Committee at any time.

 3.4 Committee Composition. To the extent required to comply with the exemption requirements of Rule
16b-3 (if the Board is not acting as the Committee under the Plan), with respect to any insider subject to Section 16 of the Exchange Act, the Committee shall be a compensation committee of the Board that
at all times consists solely of two or more Non-Employee Directors. Within the scope of such authority, the Committee may delegate to a committee of one or more members of the Board who are not Non-Employee Directors, or one or more officers of the Company or any of its Subsidiaries, the authority to grant Awards to eligible Persons who are not then subject to Section 16 of the Exchange Act. Nothing
herein shall create an inference that an Award is not validly granted under the Plan in the event Awards are granted under the Plan by a Committee that does not at all times consist solely of two or more
Non-Employee Directors. 
 3.5 Indemnification. In addition to such other rights of
indemnification as they may have as Directors or members of the Committee, and to the extent allowed by Applicable Laws, the Committee shall be indemnified by the Company against the reasonable expenses, including attorney’s fees, actually
incurred in connection with any action, suit or proceeding or in connection with any appeal therein, to which the Committee may be party by reason of any action taken or failure to act under or in connection with the Plan or any Award granted under
the Plan, and against all amounts paid by the Committee in settlement thereof (provided, however, that the settlement has been approved by the Company, which approval shall not be unreasonably withheld) or paid by the Committee in
satisfaction of a judgment in any such action, suit or proceeding, except in relation to matters as to which it shall be adjudged in such action, suit or 

  
 10 

 
proceeding that such Committee did not act in good faith and in a manner which such Person reasonably believed to be in the best interests of the Company, or in the case of a criminal proceeding,
had no reason to believe that the conduct complained of was unlawful; provided, however, that within 60 days after the institution of any such action, suit or proceeding, such Committee shall, in writing, offer the Company the opportunity at
its own expense to handle and defend such action, suit or proceeding. 
 4. Shares Subject to the Plan. 

4.1 Subject to adjustment in accordance with Section 14, no more than 13,400,000 shares of Common Stock shall be available for the grant
of Awards under the Plan (the “Total Share Reserve”) and such Total Share Reserve shall be available for the issuance of shares upon the exercise of ISOs (the “ISO Limit”). During the terms of the
Awards, the Company shall keep available at all times the number of shares of Common Stock required to satisfy such Awards. 
 4.2 Shares of
Common Stock available for distribution under the Plan may consist, in whole or in part, of authorized and unissued shares, treasury shares or shares reacquired by the Company in any manner. 

4.3 The maximum number of shares of Common Stock subject to Awards granted during a single Fiscal Year to any Director in respect of such
Director’s service as a member of the Board during such Fiscal Year, together with any cash fees paid to such Director during the Fiscal Year shall not exceed a total value of $250,000 (calculating the value of any Awards based on the
grant date fair value for financial reporting purposes). Notwithstanding the foregoing, the Committee or a subcommittee thereof delegated by the Committee that consists solely of two or more Non-Employee
Directors may provide, in its discretion, for exceptions to this limit for a Non-Employee Director, provided that the Non-Employee Director receiving such
additional compensation may not participate in the decision to award such compensation. 
 4.4 Any shares of Common Stock subject to an Award
that expires or is canceled, forfeited, or terminated without issuance of the full number of shares of Common Stock to which the Award related will again be available for issuance under the Plan. Shares subject to an Award under the Plan shall be
deemed to constitute shares not issued to the Participant and shall be deemed to again be made available for issuance or delivery under the Plan if such shares are (a) shares tendered in payment of an Option, (b) shares delivered or
withheld by the Company to satisfy any tax withholding obligation, or (c) shares covered by a stock-settled Stock Appreciation Right or other Awards that were not issued upon the settlement of the Award. If an Award may be settled only in cash,
such Award need not be counted against any share limit under this Section 4. 
 4.5 Awards may, in the sole discretion of the Committee,
be granted under the Plan in assumption of, or in substitution for, outstanding awards previously granted by an entity acquired by the Company or with which the Company combines (“Substitute Awards”). Substitute Awards shall not be
counted against the Total Share Reserve; provided, that, Substitute Awards issued in connection with the assumption of, or in substitution for, outstanding options intended to qualify as Incentive Stock Options shall be counted against the
ISO limit. Subject to applicable stock exchange requirements, available shares under a stockholder-approved plan of an entity directly or indirectly acquired by the Company or with which the Company combines (as appropriately adjusted to reflect
such acquisition or transaction) may be used for Awards under the Plan and shall not count toward the Total Share Reserve. 

  
 11 

 5. Eligibility. 

5.1 Eligibility for Specific Awards. Incentive Stock Options may be granted only to Employees. Awards other than Incentive Stock Options
may be granted to Employees, Consultants and Independent Directors and those individuals whom the Committee determines are reasonably expected to become Employees, Consultants and Independent Directors following the Grant Date. 

5.2 Ten Percent Stockholders. A Ten Percent Stockholder shall not be granted an Incentive Stock Option unless the Option Exercise Price
is at least 110% of the Fair Market Value of the Common Stock on the Grant Date and the Option is not exercisable after the expiration of five years from the Grant Date. 

6. Option Provisions. Each Option granted under the Plan shall be evidenced by an Award Agreement. Each Option so granted shall be
subject to the conditions set forth in Section 5 and this Section 6, and to such other conditions not inconsistent with the Plan as may be set forth in the applicable Award Agreement. All Options shall be separately designated Incentive
Stock Options or Non-qualified Stock Options at the time of grant, and, if certificates are issued, a separate certificate or certificates will be issued for shares of Common Stock purchased on exercise of
each type of Option. Notwithstanding the foregoing, the Company shall have no liability to any Participant or any other Person if an Option designated as an Incentive Stock Option fails to qualify as such at any time or if an Option is determined to
constitute “nonqualified deferred compensation” within the meaning of Section 409A of the Code and the terms of such Option do not satisfy the requirements of Section 409A of the Code. The provisions of separate Options need not
be identical, but each Option shall include (through incorporation of provisions hereof by reference in the Option or otherwise) the substance of each of the following provisions: 

6.1 Term. Subject to the provisions of Section 5.2 regarding Ten Percent Stockholders, no Incentive Stock Option shall be
exercisable after the expiration of 10 years from the Grant Date. The term of a Non-qualified Stock Option granted under the Plan shall be determined by the Committee; provided, however, no Non-qualified Stock Option shall be exercisable after the expiration of 10 years from the Grant Date. 

6.2 Exercise Price of an Incentive Stock Option. Subject to the provisions of Section 5.2 regarding Ten Percent Stockholders, the
Option Exercise Price of each Incentive Stock Option shall be not less than 100% of the Fair Market Value of the Common Stock subject to the Option on the Grant Date. Notwithstanding the foregoing, an Incentive Stock Option may be granted with an
Option Exercise Price lower than that set forth in the preceding sentence if such Option is granted pursuant to an assumption or substitution for another option in a manner satisfying the provisions of Section 424(a) of the Code. 

6.3 Exercise Price of a Non-qualified Stock Option. The Option Exercise Price of each Non-qualified Stock Option shall be not less than 100% of the Fair Market Value of the Common Stock subject to the Option on the Grant Date. Notwithstanding the foregoing, a Non-qualified Stock Option may be granted
with an Option Exercise Price lower than that set forth in the preceding sentence if such Option is granted pursuant to an assumption or substitution for another option in a manner satisfying the provisions of Section 409A of the Code. 

  
 12 

 6.4 Consideration. The Option Exercise Price of Common Stock acquired pursuant to an
Option shall be paid, to the extent permitted by Applicable Laws, either (a) in cash or by certified or bank check at the time the Option is exercised or (b) in the discretion of the Committee, upon such terms as the Committee shall
approve: (i) by delivery to the Company of other Common Stock, duly endorsed for transfer to the Company, with a Fair Market Value on the date of delivery equal to the Option Exercise Price (or portion thereof) due for the number of shares
being acquired, or by means of attestation whereby the Participant identifies for delivery specific shares of Common Stock that have an aggregate Fair Market Value on the date of attestation equal to the Option Exercise Price (or portion thereof)
and receives a number of shares of Common Stock equal to the difference between the number of shares thereby purchased and the number of identified attestation shares of Common Stock (a “Stock for Stock Exchange”); (ii) a
“cashless” exercise program established with a broker; (iii) by reduction in the number of shares of Common Stock otherwise deliverable upon exercise of such Option with a Fair Market Value equal to the aggregate Option Exercise Price
at the time of exercise; (iv) by any combination of the foregoing methods; or (v) in any other form of legal consideration that may be acceptable to the Committee. Unless otherwise specifically provided in the Option, the exercise price of
Common Stock acquired pursuant to an Option that is paid by delivery (or attestation) to the Company of other Common Stock acquired, directly or indirectly from the Company, shall be paid only by shares of the Common Stock of the Company that have
been held for more than six months (or such longer or shorter period of time required to avoid a charge to earnings for financial accounting purposes). Notwithstanding the foregoing, during any period for which the Common Stock is publicly traded
(i.e., the Common Stock is listed on any established stock exchange or a national market system) an exercise by a Director who is not an Independent Director or by an Officer that involves or may involve a direct or indirect extension of credit or
arrangement of an extension of credit by the Company, directly or indirectly, in violation of Section 402(a) of the Sarbanes-Oxley Act of 2002 shall be prohibited with respect to any Award under the Plan. 

6.5 Transferability of an Incentive Stock Option. An Incentive Stock Option shall not be transferable except by will or by the laws of
descent and distribution and shall be exercisable during the lifetime of the Optionholder only by the Optionholder. Notwithstanding the foregoing, the Optionholder may, by delivering written notice to the Company, in a form satisfactory to the
Company, designate a third party who, in the event of the death of the Optionholder, shall thereafter be entitled to exercise the Option. 

6.6 Vesting of Options. Options granted under the Plan shall be subject to such restrictions and limitations described in the Award
Agreement as the Committee may impose in its discretion, including vesting conditions, restrictions on exercise, and forfeiture provisions. In its discretion, the Committee may provide in the Award Agreement that some or all of such
restrictions shall lapse upon (a) the Participant’s Continuous Service with the Company or an Affiliate for a specified period of time, (b) the occurrence of any one or more other events or the satisfaction of any one or more other
conditions, as specified by the Committee, including satisfaction of Performance Criteria, a termination of Continuous Services under certain circumstances (such as death or Disability), or a Change in Control, or (c) a combination of any of
the foregoing. In its discretion, the Committee shall have the authority to accelerate the vesting of an Option at any time, in whole or in part, or otherwise waive or modify any such restrictions. 

  
 13 

 6.7 Termination of Continuous Service. Unless otherwise provided in an Award
Agreement or in an employment agreement the terms of which have been approved by the Committee, in the event an Optionholder’s Continuous Service terminates (other than upon the Optionholder’s death or Disability), the Optionholder may
exercise his or her Option (to the extent that the Optionholder was entitled to exercise such Option as of the date of termination) but only within such period of time ending on the earlier of (a) the date three months following the termination
of the Optionholder’s Continuous Service or (b) the expiration of the term of the Option as set forth in the Award Agreement; provided that, if the termination of Continuous Service is by the Company for Cause, all outstanding
Options (whether or not vested) shall immediately terminate and cease to be exercisable. If, after termination, the Optionholder does not exercise his or her Option within the time specified in the Award Agreement, the Option shall terminate. 

6.8 Extension of Termination Date. An Optionholder’s Award Agreement may also provide that if the exercise of the Option following
the termination of the Optionholder’s Continuous Service for any reason would be prohibited at any time because the issuance of shares of Common Stock would violate the registration requirements under the Securities Act or any other state or
federal securities law or the rules of any securities exchange or interdealer quotation system, then the Option shall terminate on the earlier of (a) the expiration of the term of the Option in accordance with Section 6.1 or (b) the
expiration of a period after termination of the Participant’s Continuous Service that is three months after the end of the period during which the exercise of the Option would be in violation of such registration or other securities law
requirements. 
 6.9 Disability of Optionholder. Unless otherwise provided in an Award Agreement, in the event that an
Optionholder’s Continuous Service terminates as a result of the Optionholder’s Disability, the Optionholder may exercise his or her Option (to the extent that the Optionholder was entitled to exercise such Option as of the date of
termination), but only within the period of time ending on the earlier of (a) the date twelve (12) months following such termination or (b) the expiration of the term of the Option as set forth in the Award Agreement. If, after
termination, the Optionholder does not exercise his or her Option within the time specified herein or in the Award Agreement, the Option shall terminate. 

6.10 Death of Optionholder. Unless otherwise provided in an Award Agreement, in the event an Optionholder’s Continuous
Service terminates as a result of the Optionholder’s death, then the Option may be exercised (to the extent that the Optionholder was entitled to exercise such Option as of the date of death) by the Optionholder’s estate, by a Person who
acquired the right to exercise the Option by bequest or inheritance or by a Person designated to exercise the Option upon the Optionholder’s death, but only within the period ending on the earlier of (a) the date 12 months following the
date of death or (b) the expiration of the term of such Option as set forth in the Award Agreement. If, after the Optionholder’s death, the Option is not exercised within the time specified herein or in the Award Agreement, the Option
shall terminate. 

  
 14 

 6.11 Incentive Stock Option $100,000 Limitation. To the extent that the aggregate
Fair Market Value (determined at the time of grant) of Common Stock with respect to which Incentive Stock Options are exercisable for the first time by any Optionholder during any calendar year (under all plans of the Company and its Affiliates)
exceeds $100,000, the Options or portions thereof which exceed such limit (according to the order in which they were granted) shall be treated as Non-qualified Stock Options. 

7. Stock Appreciation Rights. Each Stock Appreciation Right granted under the Plan shall be evidenced by an Award Agreement. Each Stock
Appreciation Right so granted shall be subject to the conditions set forth in this Section 7, and to such other conditions not inconsistent with the Plan as may be reflected in the applicable Award Agreement. Stock Appreciation Rights may be
granted alone (“Free Standing Rights”) or in tandem with an Option granted under the Plan (“Related Rights”). 

7.1 Grant Requirements for Related Rights. Any Related Right that relates to a
Non-qualified Stock Option may be granted at the same time the Option is granted or at any time thereafter but before the exercise or expiration of the Option. Any Related Right that relates to an Incentive
Stock Option must be granted at the same time the Incentive Stock Option is granted. 
 7.2 Term The term of a Stock Appreciation
Right granted under the Plan shall be determined by the Committee; provided, however, no Stock Appreciation Right shall be exercisable later than the tenth anniversary of the Grant Date. 

7.3 Vesting. Stock Appreciation Rights under the Plan shall be subject to such restrictions and limitations set forth in the Award
Agreement as the Committee may impose in its discretion, including vesting conditions and forfeiture provisions. In its discretion, the Committee may provide in the Award Agreement that some or all of such restrictions shall lapse upon
(a) the Participant’s continued employment with the Company or an Affiliate for a specified period of time, (b) the occurrence of any one or more other events or the satisfaction of any one or more other conditions, as specified by
the Committee, including satisfaction of performance criteria, a termination of Continuous Services under certain circumstances (such as death or Disability), or a Change in Control, or (c) a combination of any of the foregoing. In its
discretion, the Committee shall have the authority to accelerate the vesting of a Stock Appreciation Right at any time, in whole or in part, or otherwise waive or modify any such restrictions. 

7.4 Exercise and Payment. Upon exercise of a Stock Appreciation Right, the holder shall be entitled to receive from the Company an
amount equal to the number of shares of Common Stock subject to the Stock Appreciation Right that is being exercised multiplied by the excess of (i) the Fair Market Value of a share of Common Stock on the date the Award is exercised, over
(ii) the exercise price specified in the Stock Appreciation Right or related Option. Payment with respect to the exercise of a Stock Appreciation Right shall be made on the date of exercise. Payment shall be made in the form of shares of Common
Stock (with or without restrictions as to substantial risk of forfeiture and transferability, as determined by the Committee in its sole discretion), cash or a combination thereof, as determined by the Committee. 

  
 15 

 7.5 Exercise Price. The exercise price of a Free Standing Right shall be determined
by the Committee, but shall not be less than 100% of the Fair Market Value of one share of Common Stock on the Grant Date of such Stock Appreciation Right. A Related Right granted simultaneously with or subsequent to the grant of an Option and in
conjunction therewith or in the alternative thereto shall have the same exercise price as the related Option, shall be transferable only upon the same terms and conditions as the related Option, and shall be exercisable only to the same extent as
the related Option; provided, however, that a Stock Appreciation Right, by its terms, shall be exercisable only when the Fair Market Value per share of Common Stock subject to the Stock Appreciation Right and related Option exceeds the
exercise price per share thereof and no Stock Appreciation Rights may be granted in tandem with an Option unless the Committee determines that the requirements of Section 7.1 are satisfied. 

7.6 Reduction in the Underlying Option Shares. Upon any exercise of a Related Right, the number of shares of Common Stock for which any
related Option shall be exercisable shall be reduced by the number of shares for which the Stock Appreciation Right has been exercised. The number of shares of Common Stock for which a Related Right shall be exercisable shall be reduced upon any
exercise of any related Option by the number of shares of Common Stock for which such Option has been exercised. 
 8. Restricted
Award. A Restricted Award is an Award of actual shares of Common Stock (“Restricted Stock”) or hypothetical Common Stock units (“Restricted Stock Units”) having a value equal to the Fair Market Value of an
identical number of shares of Common Stock, which may, but need not, provide that such Restricted Award may not be sold, assigned, transferred or otherwise disposed of, pledged or hypothecated as collateral for a loan or as security for the
performance of any obligation or for any other purpose for such period (the “Restricted Period”) as the Committee shall determine. Each Restricted Award granted under the Plan shall be evidenced by an Award Agreement. Each
Restricted Award so granted shall be subject to the conditions set forth in this Section 8, and to such other conditions not inconsistent with the Plan as may be set forth in the applicable Award Agreement. 

8.1 Restricted Stock and Restricted Stock Units. 

(a) Each Participant granted Restricted Stock shall execute and deliver to the Company an Award Agreement with respect to the Restricted Stock
setting forth the restrictions and other terms and conditions applicable to such Restricted Stock. If the Committee determines that the Restricted Stock shall be held by the Company or in escrow rather than delivered to the Participant pending the
release of the applicable restrictions, the Committee may require the Participant to additionally execute and deliver to the Company (A) an escrow agreement satisfactory to the Committee, if applicable and (B) the appropriate blank stock
power with respect to the Restricted Stock covered by such agreement. If a Participant fails to execute an agreement evidencing an Award of Restricted Stock and, if applicable, an escrow agreement and stock power, the Award shall be null and void.
Subject to the restrictions set forth in the Award, the Participant generally shall have the rights and privileges of a stockholder as to such Restricted Stock, including the right to vote such Restricted Stock and the right to receive dividends;
provided that, any cash dividends and stock dividends with respect to the Restricted Stock shall be withheld by the Company for the Participant’s account, and interest may be credited on the amount of the cash dividends withheld at a
rate and subject to such terms as determined by the Committee. The cash dividends or stock dividends so withheld by the Committee and attributable to any particular share of Restricted Stock (and earnings thereon, if applicable) shall be distributed
to the Participant in cash or, at the discretion of the Committee, in shares of Common Stock having a Fair Market Value equal to the amount of such dividends, if applicable, upon the release of restrictions on such share and, if such share is
forfeited, the Participant shall have no right to such dividends. 

  
 16 

 (b) The terms and conditions of a grant of Restricted Stock Units shall be reflected in an
Award Agreement. No shares of Common Stock shall be issued at the time a Restricted Stock Unit is granted, and the Company will not be required to set aside funds for the payment of any such Award. A Participant shall have no voting rights with
respect to any Restricted Stock Units granted hereunder. The Committee may also grant Restricted Stock Units with a deferral feature, whereby settlement is deferred beyond the vesting date until the occurrence of a future payment date or event set
forth in an Award Agreement (“Deferred Stock Units”). At the discretion of the Committee, each Restricted Stock Unit or Deferred Stock Unit (representing one share of Common Stock) may be credited with an amount equal to the cash
and stock dividends paid by the Company in respect of one share of Common Stock (“Dividend Equivalents”). 
 (c) Dividend
Equivalents shall be withheld by the Company and credited to the Participant’s account, and interest may be credited on the amount of cash Dividend Equivalents credited to the Participant’s account at a rate and subject to such terms as
determined by the Committee. Dividend Equivalents credited to a Participant’s account and attributable to any particular Restricted Stock Unit or Deferred Stock Unit (and earnings thereon, if applicable) shall be distributed in cash or, at the
discretion of the Committee, in shares of Common Stock having a Fair Market Value equal to the amount of such Dividend Equivalents and earnings, if applicable, to the Participant upon settlement of such Restricted Stock Unit or Deferred Stock Unit
and, if such Restricted Stock Unit or Deferred Stock Unit is forfeited, the Participant shall have no right to such Dividend Equivalents. 

8.2 Restrictions. 
 (a)
Restricted Stock awarded to a Participant shall be subject to the following restrictions until the expiration of the Restricted Period, and to such other terms and conditions as may be set forth in the applicable Award Agreement: (A) if an
escrow arrangement is used, the Participant shall not be entitled to delivery of the stock certificate; (B) the shares shall be subject to the restrictions on transferability set forth in the Award Agreement; (C) the shares shall be
subject to forfeiture to the extent provided in the applicable Award Agreement; and (D) to the extent such shares are forfeited, the stock certificates shall be returned to the Company, and all rights of the Participant to such shares and as a
stockholder with respect to such shares shall terminate without further obligation on the part of the Company. 
 (b) Restricted Stock Units
and Deferred Stock Units awarded to any Participant shall be subject to (A) forfeiture until the expiration of the Restricted Period, and satisfaction of any applicable Performance Goals during such period, to the extent provided in the
applicable Award Agreement, and to the extent such Restricted Stock Units or Deferred Stock Units are forfeited, all rights of the Participant to such Restricted Stock Units or Deferred Stock Units shall terminate without further obligation on the
part of the Company and (B) such other terms and conditions as may be set forth in the applicable Award Agreement. 

  
 17 

 (c) The Committee shall have the authority to remove any or all of the restrictions on the
Restricted Stock, Restricted Stock Units and Deferred Stock Units whenever it may determine that, by reason of changes in Applicable Laws or other changes in circumstances arising after the date the Restricted Stock or Restricted Stock Units or
Deferred Stock Units are granted, such action is appropriate. 
 8.3 Restricted Period. With respect to Restricted Awards, the
Restricted Period shall commence on the Grant Date and end at the time or times set forth on a schedule established by the Committee in the applicable Award Agreement. 

8.4 Delivery of Restricted Stock and Settlement of Restricted Stock Units. Upon the expiration of the Restricted Period with respect to
any shares of Restricted Stock, the restrictions set forth in Section 8.2 and the applicable Award Agreement shall be of no further force or effect with respect to such shares, except as set forth in the applicable Award Agreement. If an escrow
arrangement is used, upon such expiration, the Company shall deliver to the Participant, or his or her beneficiary, without charge, the stock certificate evidencing the shares of Restricted Stock which have not then been forfeited and with respect
to which the Restricted Period has expired (to the nearest full share) and any cash dividends or stock dividends credited to the Participant’s account with respect to such Restricted Stock and the interest thereon, if any. Upon the expiration
of the Restricted Period with respect to any outstanding Restricted Stock Units, or at the expiration of the deferral period with respect to any outstanding Deferred Stock Units, the Company shall deliver to the Participant, or his or her
beneficiary, without charge, one share of Common Stock for each such outstanding vested Restricted Stock Unit or Deferred Stock Unit (“Vested Unit”) and cash equal to any Dividend Equivalents credited with respect to each such
Vested Unit in accordance with Section 8.1(b) hereof and the interest thereon or, at the discretion of the Committee, in shares of Common Stock having a Fair Market Value equal to such Dividend Equivalents and the interest thereon, if any;
provided, however, that, if explicitly provided in the applicable Award Agreement, the Committee may, in its sole discretion, elect to pay cash or part cash and part Common Stock in lieu of delivering only shares of Common Stock for Vested
Units. If a cash payment is made in lieu of delivering shares of Common Stock, the amount of such payment shall be equal to the Fair Market Value of the Common Stock as of the date on which the Restricted Period lapsed in the case of Restricted
Stock Units, or the delivery date in the case of Deferred Stock Units, with respect to each Vested Unit. 
 8.5 Stock Restrictions.
Each certificate representing Restricted Stock awarded under the Plan shall bear a legend in such form as the Company deems appropriate. 

9. Performance Share Awards. Each Performance Share Award granted under the Plan shall be evidenced by an Award Agreement. Each
Performance Share Award so granted shall be subject to the conditions set forth in this Section 9, and to such other conditions not inconsistent with the Plan as may be set forth in the applicable Award Agreement. The Committee shall have the
discretion to determine: (i) the number of shares of Common Stock or stock-denominated units subject to a Performance Share Award granted to any Participant; (ii) the Performance Period applicable to any Award; (iii) the conditions
that must be satisfied for a Participant to earn an Award; and (iv) the other terms, conditions and restrictions of the Award. 
 9.1
Earning Performance Share Awards The number of Performance Shares earned by a Participant will depend on the extent to which the Performance Goals established by the Committee are attained within the applicable Performance Period, as
determined by the Committee. 

  
 18 

 10. Other Equity-Based Awards and Cash Awards The Committee may grant Other
Equity-Based Awards, either alone or in tandem with other Awards, in such amounts and subject to such conditions as the Committee shall determine in its sole discretion. Each Other Equity-Based Award shall be evidenced by an Award Agreement and
shall be subject to such conditions, not inconsistent with the Plan, as may be set forth in the applicable Award Agreement. The Committee may grant Cash Awards in such amounts and subject to such Performance Goals, other vesting conditions, and such
other terms as the Committee determines in its discretion. Cash Awards shall be evidenced in such form as the Committee may determine. 
 11.
Securities Law Compliance. Each Award Agreement shall provide that no shares of Common Stock shall be purchased or sold thereunder unless and until (a) any then applicable requirements of state and federal laws and regulatory agencies
have been fully complied with to the satisfaction of the Company and its counsel and (b) if required to do so by the Company, the Participant has executed and delivered to the Company a letter of investment intent in such form and containing
such provisions as the Committee may require. The Company shall use reasonable efforts to seek to obtain from each regulatory commission or agency having jurisdiction over the Plan such authority as may be required to grant Awards and to issue and
sell shares of Common Stock upon exercise of the Awards; provided, however, that this undertaking shall not require the Company to register under the Securities Act the Plan, any Award or any Common Stock issued or issuable pursuant to any
such Award. If, after reasonable efforts, the Company is unable to obtain from any such regulatory commission or agency the authority which counsel for the Company deems necessary for the lawful issuance and sale of Common Stock under the Plan, the
Company shall be relieved from any liability for failure to issue and sell Common Stock upon exercise of such Awards unless and until such authority is obtained. 

12. Use of Proceeds from Stock. Proceeds from the sale of Common Stock pursuant to Awards, or upon exercise thereof, shall constitute
general funds of the Company. 
 13. Miscellaneous. 

13.1 Stockholder Rights. Except as provided in the Plan or an Award Agreement, no Participant shall be deemed to be the holder of, or to
have any of the rights of a holder with respect to, any shares of Common Stock subject to such Award unless and until such Participant has satisfied all requirements for exercise of the Award pursuant to its terms and no adjustment shall be made for
dividends (ordinary or extraordinary, whether in cash, securities or other property) or distributions of other rights for which the record date is prior to the date such Common Stock certificate is issued, except as provided in Section 14
hereof. 
 13.2 No Employment or Other Service Rights. Nothing in the Plan or any instrument executed or Award granted pursuant
thereto shall confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Award was granted or shall affect the right of the Company or an Affiliate to terminate (a) the
employment of an Employee with or without notice and with or without Cause or (b) the service of a Director pursuant to the By-laws of the Company or an Affiliate, and any applicable provisions of the
corporate law of the state in which the Company or the Affiliate is incorporated, as the case may be. 

  
 19 

 13.3 Transfer; Approved Leave of Absence. For purposes of the Plan, no termination of
employment by an Employee shall be deemed to result from either (a) a transfer of employment to the Company from an Affiliate or from the Company to an Affiliate, or from one Affiliate to another, or (b) an approved leave of absence for
military service or sickness, or for any other purpose approved by the Company, if the Employee’s right to reemployment is guaranteed either by a statute or by contract or under the policy pursuant to which the leave of absence was granted or
if the Committee otherwise so provides in writing, in either case, except to the extent inconsistent with Section 409A of the Code if the applicable Award is subject thereto. 

13.4 Withholding Obligations. To the extent provided by the terms of an Award Agreement and subject to the discretion of the Committee,
the Participant may satisfy any federal, state or local tax withholding obligation relating to the exercise or acquisition of Common Stock under an Award by any of the following means (in addition to the Company’s right to withhold from any
compensation paid to the Participant by the Company) or by a combination of such means: (a) tendering a cash payment; (b) authorizing the Company to withhold shares of Common Stock from the shares of Common Stock otherwise issuable to the
Participant as a result of the exercise or acquisition of Common Stock under the Award, provided, however, that no shares of Common Stock are withheld with a value exceeding the maximum amount of tax required to be withheld by law; or
(c) delivering to the Company previously owned and unencumbered shares of Common Stock of the Company. 
 13.5 Permitted
Transfers. Awards (other than Incentive Stock Options) may, in the sole discretion of the Committee, be transferable to a Permitted Transferee upon written approval by the Committee. 

14. Adjustments Upon Changes in Stock. Notwithstanding any other provision in this Plan to the contrary, the following
provisions shall apply to all Awards granted hereunder: 
 14.1 General. In the event of (a) any dividend (other than regular
cash dividends) or other distribution (whether in the form of cash, shares of Common Stock, other securities, or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, split-off, spin-off, combination, repurchase, or exchange of shares of Common Stock or other securities of the Company,
issuance of warrants or other rights to acquire shares of Common Stock or other securities of the Company, or other similar corporate transaction or event that affects the shares of Common Stock (including a Change in Control), or (b) unusual
or nonrecurring events affecting the Company, including changes in applicable rules, rulings, regulations, or other requirements, that the Committee determines, in its sole discretion, could result in dilution or enlargement of the rights intended
to be granted to, or available for, Participants (any event in (a) or (b), an “Adjustment Event”), the Committee shall, in respect of any such Adjustment Event, make such proportionate substitution or adjustment, if any, as it
deems equitable, to any or all of: (i) the Total Share Reserve, or any other limit applicable under the Plan with respect to the number of Awards which may be granted hereunder; (ii) the number of shares of Common Stock or other securities
of the Company (or number and kind of other securities or other property) which may be issued in respect of Awards or with respect to which Awards may 

  
 20 

 
be granted under the Plan; and (iii) the terms of any outstanding Award, including, without limitation, (A) the number of shares of Common Stock or other securities of the Company (or
number and kind of other securities or other property) subject to outstanding Awards or to which outstanding Awards relate; (B) the exercise price with respect to any Award; or (C) any applicable performance measures; provided, that
in the case of any “equity restructuring” (within the meaning of the Financial Accounting Standards Board Accounting Standards Codification Topic 718 (or any successor pronouncement thereto)), the Committee shall make an equitable or
proportionate adjustment to outstanding Awards to reflect such equity restructuring. In the case of adjustments made pursuant to this Section 14, unless the Committee specifically determines that such adjustment is in the best interests of the
Company or its Affiliates, the Committee shall, in the case of Incentive Stock Options, ensure that any adjustments under this Section 14 will not constitute a modification, extension or renewal of the Incentive Stock Options within the meaning
of Section 424(h)(3) of the Code and in the case of Non-qualified Stock Options, ensure that any adjustments under this Section 14 will not constitute a modification of such Non-qualified Stock Options within the meaning of Section 409A of the Code. Any adjustments made under this Section 14 shall be made in a manner which does not adversely affect the exemption provided
pursuant to Rule 16b-3 under the Exchange Act. The Company shall give each Participant notice of an adjustment hereunder and, upon notice, such adjustment shall be final, conclusive and binding for all
purposes. 
 14.2 Adjustment Events. Without limiting the foregoing, except as may otherwise be provided in an Award Agreement, in
connection with any Adjustment Event, the Committee may, in its sole discretion, provide for any one or more of the following, which may vary among individual holders and which may vary among Awards held by any individual holder: 

(a) acceleration of the time of exercisability of an Award so that such Award may be exercised in full or in part for a limited period of time
on or before a date specified by the Committee, after which specified date all unexercised Awards and all rights of holders thereunder shall terminate; 

(b) cancellation of Awards that remain subject to a restricted period as of the date of such Adjustment Event without payment of any
consideration to the Participant for such Awards; or 
 (c) substitution or assumption of Awards (or awards of an acquiring company),
acceleration of the exercisability of, lapse of restrictions on, or termination of Awards, or a period of time (which shall not be required to be more than ten days) for Participants to exercise outstanding Awards prior to the occurrence of such
event (and any such Award not so exercised shall terminate upon the occurrence of such event); and 
 (d) subject to any limitations or
reductions as may be necessary to comply with Section 409A of the Code, cancellation of any one or more outstanding Awards and payment to the holders of such Awards that are vested as of such cancellation (including, without limitation, any
Awards that would vest as a result of the occurrence of such event but for such cancellation or for which vesting is accelerated by the Committee in connection with such event) the value of such Awards, if any, as determined by the Committee (which
value, if applicable, may be based upon the price per share of Common Stock received or to be received by other stockholders of the Company in such event), including, without limitation: 

  
 21 

 (i) in the case of an outstanding Option or Stock Appreciation Right, a cash payment in an
amount equal to the excess, if any, of the Fair Market Value (as of a date specified by the Committee) of the shares of Common Stock subject to such Option or Stock Appreciation Right over the aggregate exercise price of such Option or Stock
Appreciation Right (it being understood that, in such event, any Option or Stock Appreciation Right having a per share exercise price equal to, or in excess of, the Fair Market Value of a share of Common Stock subject thereto may be canceled and
terminated without any payment or consideration therefor), or 
 (ii) in the case of Restricted Stock, Restricted Stock Units, Performance
Share Awards, Cash Awards or Other Equity-Based Awards that are not vested as of such cancellation, a cash payment or equity subject to deferred vesting and delivery consistent with the vesting restrictions applicable to such Restricted Stock,
Restricted Stock Units, Performance Share Awards, Cash Awards or Other Equity-Based Awards prior to cancellation, or the underlying shares in respect thereof, with Performance Goals with respect to each outstanding Performance Period, if any, that
are applicable to such Awards deemed to be achieved at the greater of 100% of the applicable “target” performance levels and the performance levels actually achieved as of the date of such event, as determined by the Committee. 

Payments to holders pursuant to clause (b) above shall be made in cash or, in the sole discretion of the Committee, in the form of such other
consideration necessary for a Participant to receive property, cash, or securities (or combination thereof) as such Participant would have been entitled to receive upon the occurrence of the transaction if the Participant had been, immediately prior
to such transaction, the holder of the number of shares of Common Stock covered by the Award at such time (less any applicable exercise price). 

14.3 Other Requirements. Prior to any payment or adjustment contemplated under this Section 14, the Committee may require a
Participant to (a) represent and warrant as to the unencumbered title to the Participant’s Awards; (b) bear such Participant’s pro rata share of any post-closing indemnity obligations, and be subject to the same post-closing
purchase price adjustments, escrow terms, offset rights, holdback terms, and similar conditions as the other holders of Common Stock, subject to any limitations or reductions as may be necessary to comply with Section 409A of the Code; and
(iii) deliver customary transfer documentation as reasonably determined by the Committee. 
 14.4 Binding Effect. Any adjustment,
substitution, determination of value or other action taken by the Committee under this Section 14 shall be final, conclusive and binding for all purposes. 

15. Amendment of the Plan and Awards. 

15.1 Amendment of Plan. The Board at any time, and from time to time, may amend or terminate the Plan. However, except as provided in
Section 14 relating to adjustments upon changes in Common Stock and Section 15.3, no amendment shall be effective unless approved by the stockholders of the Company to the extent stockholder approval is necessary to satisfy any Applicable
Laws. At the time of such amendment, the Board shall determine, upon advice from counsel, whether such amendment will be contingent on stockholder approval. 

  
 22 

 15.2 Stockholder Approval. The Board may, in its sole discretion, submit any other
amendment to the Plan for stockholder approval. 
 15.3 Contemplated Amendments. It is expressly contemplated that the Board may amend
the Plan in any respect the Board deems necessary or advisable to provide eligible Employees, Consultants and Independent Directors with the maximum benefits provided or to be provided under the provisions of the Code and the regulations promulgated
thereunder relating to Incentive Stock Options or to the nonqualified deferred compensation provisions of Section 409A of the Code and/or to bring the Plan and/or Awards granted under it into compliance therewith. 

15.4 No Impairment of Rights. Rights under any Award granted before amendment of the Plan shall not be materially impaired by any
amendment of the Plan unless (a) the Company requests the consent of the Participant and (b) the Participant consents in writing. 

15.5 Amendment of Awards. The Committee at any time, and from time to time, may amend the terms of any one or more Awards; provided,
however, that the Committee may not affect any amendment which would otherwise constitute an impairment of the rights under any Award unless (a) the Company requests the consent of the Participant and (b) the Participant consents in
writing. 
 16. General Provisions. 

16.1 Forfeiture Events. The Committee may specify in an Award Agreement that the Participant’s rights, payments and benefits with
respect to an Award shall be subject to reduction, cancellation, forfeiture or recoupment upon the occurrence of certain events, in addition to applicable vesting conditions of an Award. Such events may include, without limitation, breach of non-competition, non-solicitation, confidentiality, or other restrictive covenants that are contained in the Award Agreement or otherwise applicable to the Participant, a
termination of the Participant’s Continuous Service for Cause, or other conduct by the Participant that is detrimental to the business or reputation of the Company and/or its Affiliates. 

16.2 Clawback. The Plan and all Awards granted hereunder are subject to any written clawback policies that the Company, with the
approval of the Board or an authorized committee thereof, may adopt either prior to or following the Effective Date, including any policy adopted to conform to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 and rules
promulgated thereunder by the SEC and that the Company determines should apply to Awards. Any such policy may subject a Participant’s Awards and amounts paid or realized with respect to Awards to reduction, cancelation, forfeiture or recoupment
if certain specified events or wrongful conduct occur, including an accounting restatement due to the Company’s material noncompliance with financial reporting regulations or other events or wrongful conduct specified in any such clawback
policy. 
 16.3 Status Under ERISA. The Plan shall not constitute an “employee benefit plan” for purposes of
Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended. 
 16.4 Other Compensation Arrangements. Nothing
contained in the Plan shall prevent the Board from adopting other or additional compensation arrangements, subject to stockholder approval if such approval is required; and such arrangements may be either generally applicable or applicable only in
specific cases. 

  
 23 

 16.5 Sub-Plans. The Committee may from time
to time establish sub-plans under the Plan for purposes of satisfying securities, tax or other laws of various jurisdictions in which the Company intends to grant Awards. Any
sub-plans shall contain such limitations and other terms and conditions as the Committee determines are necessary or desirable. All sub-plans shall be deemed a part of
the Plan, but each sub-plan shall apply only to the Participants in the jurisdiction for which the sub-plan was designed. 

16.6 Deferral of Awards. The Committee may establish one or more programs under the Plan to permit selected Participants the opportunity
to elect to defer receipt of consideration upon exercise of an Award, satisfaction of performance criteria, or other event that absent the election would entitle the Participant to payment or receipt of shares of Common Stock or other consideration
under an Award. The Committee may establish the election procedures, the timing of such elections, the mechanisms for payments of, and accrual of interest or other earnings, if any, on amounts, shares or other consideration so deferred, and such
other terms, conditions, rules and procedures that the Committee deems advisable for the administration of any such deferral program. 
 16.7
Unfunded Plan. The Plan shall be unfunded. Neither the Company, the Board nor the Committee shall be required to establish any special or separate fund or to segregate any assets to assure the performance of its obligations under the Plan.

 16.8 Delivery. Upon exercise of a right granted under the Plan, the Company shall issue Common Stock or pay any amounts due within
a reasonable period of time thereafter. Subject to any statutory or regulatory obligations the Company may otherwise have, for purposes of the Plan, 30 days shall be considered a reasonable period of time. 

16.9 No Fractional Shares. No fractional shares of Common Stock shall be issued or delivered pursuant to the Plan, including pursuant to
any adjustment under Section 14. The Committee shall determine whether cash, additional Awards or other securities or property shall be issued or paid in lieu of fractional shares of Common Stock or whether any fractional shares should be
rounded, forfeited or otherwise eliminated. 
 16.10 Other Provisions. The Award Agreements authorized under the Plan may contain such
other provisions not inconsistent with the Plan, including, without limitation, restrictions upon the exercise of Awards, as the Committee may deem advisable. 

16.11 Section 409A. The Plan is intended to comply with Section 409A of the Code to the extent subject thereto,
and, accordingly, to the maximum extent permitted, the Plan shall be interpreted and administered to be in compliance therewith. Any payments described in the Plan that are due within the “short-term deferral period” as defined in
Section 409A of the Code shall not be treated as deferred compensation unless Applicable Laws require otherwise. Notwithstanding anything to the contrary in the Plan, to the extent required to avoid accelerated taxation and tax penalties under
Section 409A of the Code, amounts that would otherwise be payable and benefits that would otherwise be provided pursuant to the Plan during the six (6) 

  
 24 

 
month period immediately following the Participant’s termination of Continuous Service shall instead be paid on the first payroll date after the
six-month anniversary of the Participant’s separation from service (or the Participant’s death, if earlier). Notwithstanding the foregoing, neither the Company nor the Committee shall have any
obligation to take any action to prevent the assessment of any additional tax or penalty on any Participant under Section 409A of the Code and neither the Company nor the Committee will have any liability to any Participant for such tax or
penalty. 
 16.12 Disqualifying Dispositions. Any Participant who shall make a “disposition” (as defined in Section 424
of the Code) of all or any portion of shares of Common Stock acquired upon exercise of an Incentive Stock Option within two years from the Grant Date of such Incentive Stock Option or within one year after the issuance of the shares of Common Stock
acquired upon exercise of such Incentive Stock Option (a “Disqualifying Disposition”) shall be required to immediately advise the Company in writing as to the occurrence of the sale and the price realized upon the sale of such
shares of Common Stock. 
 16.13 Section 16. It is the intent of the Company that the Plan satisfy, and be
interpreted in a manner that satisfies, the applicable requirements of Rule 16b-3 as promulgated under Section 16 of the Exchange Act so that Participants will be entitled to the benefit of Rule 16b-3, or any other rule promulgated under Section 16 of the Exchange Act, and will not be subject to short-swing liability under Section 16 of the Exchange Act. Accordingly, if the operation of any
provision of the Plan would conflict with the intent expressed in this Section 16.12, such provision to the extent possible shall be interpreted and/or deemed amended so as to avoid such conflict. 

16.14 Beneficiary Designation. Each Participant under the Plan may from time to time name any beneficiary or beneficiaries by whom any
right under the Plan is to be exercised in case of such Participant’s death. Each designation will revoke all prior designations by the same Participant, shall be in a form reasonably prescribed by the Committee and shall be effective only when
filed by the Participant in writing with the Company during the Participant’s lifetime. 
 16.15 Expenses. The costs of
administering the Plan shall be paid by the Company. 
 16.16 Severability. If any of the provisions of the Plan or any Award
Agreement is held to be invalid, illegal or unenforceable, whether in whole or in part, such provision shall be deemed modified to the extent, but only to the extent, of such invalidity, illegality or unenforceability and the remaining provisions
shall not be affected thereby. 
 16.17 Plan Headings. The headings in the Plan are for purposes of convenience only and are not
intended to define or limit the construction of the provisions hereof. 
 16.18 Non-Uniform
Treatment. The Committee’s determinations under the Plan need not be uniform and may be made by it selectively among Persons who are eligible to receive, or actually receive, Awards. Without limiting the generality of the foregoing, the
Committee shall be entitled to make non-uniform and selective determinations, amendments and adjustments, and to enter into non-uniform and selective Award Agreements.

 17. Effective Date of Plan. The Plan shall become effective as of the Effective Date. 

  
 25 

 18. Termination or Suspension of the Plan. The Plan shall terminate automatically on
December 29, 2020. No Award shall be granted pursuant to the Plan after such date, but Awards theretofore granted may extend beyond that date. The Board may suspend or terminate the Plan at any earlier date pursuant to Section 15.1 hereof.
No Awards may be granted under the Plan while the Plan is suspended or after it is terminated. 
 19. Choice of Law. The law of the
State of Delaware shall govern all questions concerning the construction, validity and interpretation of the Plan, without regard to such state’s conflict of law rules. 

As adopted by the Board of Directors of Rush Street Interactive, Inc. on November 17, 2020. 

As approved by the stockholders of Rush Street Interactive, Inc. on December 29, 2020. 

  
 26EX-10.1

 Exhibit 10.1 

Execution Version 
 EQM
MIDSTREAM PARTNERS, LP 
 $800,000,000 4.50% Senior Notes due 2029 

$1,100,000,000 4.75% Senior Notes due 2031 

Purchase Agreement 

January 4, 2021 
 Barclays Capital Inc. 

As Representative of the 
 several
Initial Purchasers listed 
 in Schedule 1 hereto 

c/o Barclays Capital Inc. 
 745 7th Avenue 

New York, New York 10019 
 Ladies and Gentlemen: 

EQM Midstream Partners, LP, a Delaware limited partnership (the “Partnership”), proposes to issue and sell to the several
initial purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for whom you are acting as representative (the “Representative”), $800,000,000 principal amount of its 4.50% Senior Notes due 2029 (the
“2029 Notes”) and $1,100,000,000 principal amount of its 4.75% Senior Notes due 2031 (the “2031 Notes” and, together with the 2029 Notes, the “Securities”). The Securities will be issued pursuant to
an Indenture to be dated as of January 8, 2021 (the “Indenture”), between the Partnership and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”). 

References herein to: (1) “Partnership Entities” shall mean the Partnership, EQGP Services, LLC, a Delaware limited
liability company and the general partner of the Partnership (the “General Partner”), and the entities set forth on Schedule 2 hereto; (2) “Assets” shall mean all of the assets that are owned and operated by
the Partnership Entities; and (3) “Organizational Documents” shall mean the Partnership Agreement (as defined below), the limited liability company agreement of the General Partner (the “GP LLC Agreement”)
and the certificate of incorporation, bylaws, certificate of formation, limited partnership agreement, limited liability company agreement or other organizational or constituent document of each other Partnership Entity, as applicable. 

In June 2020, the Partnership completed a merger pursuant to which it became a wholly owned subsidiary of Equitrans Midstream Corporation, a
Pennsylvania corporation (“Equitrans”), and delisted all registered securities of the Partnership in August 2020. 

 In connection with the offering of the Securities, the Partnership will conduct tender
offers for its 4.750% senior notes due 2023 in the aggregate principal amount of $1,100,000,000 and 4.000% senior notes due 2024 in the aggregate principal amount of $500,000,000 upon the terms and subject to the conditions set forth in that certain
Offer to Purchase, dated January 4, 2021. 
 The Partnership hereby confirms its agreement with the several Initial Purchasers
concerning the purchase and resale of the Securities, as follows: 
 1. Offering Memorandum and Transaction Information. 

The Securities will be sold to the Initial Purchasers without being registered under the Securities Act of 1933, as amended (the
“Securities Act”), in reliance upon an exemption therefrom. The Partnership has prepared a preliminary offering memorandum dated January 4, 2021 (the “Preliminary Offering Memorandum”) and will prepare an
offering memorandum dated the date hereof (the “Offering Memorandum”) setting forth information concerning the Partnership and the Securities. Copies of the Preliminary Offering Memorandum have been, and copies of the Offering
Memorandum will be, delivered by the Partnership to the Initial Purchasers pursuant to the terms of this purchase agreement (the “Agreement”). The Partnership hereby confirms that it has authorized the use of the Preliminary
Offering Memorandum, the other Time of Sale Information (as defined below) and the Offering Memorandum in connection with the offering and resale of the Securities by the Initial Purchasers in the manner contemplated by this Agreement. References
herein to the Preliminary Offering Memorandum, the Time of Sale Information and the Offering Memorandum shall be deemed to refer to and include any document incorporated by reference therein and any reference to “amend,”
“amendment” or “supplement” with respect to the Preliminary Offering Memorandum or the Offering Memorandum shall be deemed to refer to and include any documents filed after such date and incorporated by reference therein.
Capitalized terms used but not defined herein shall have the meanings given to such terms in the Preliminary Offering Memorandum. 
 At or
prior to the time when sales of the Securities were first made (the “Time of Sale”), the Partnership had prepared the following information (collectively, the “Time of Sale Information”): the Preliminary Offering
Memorandum, as supplemented and amended by the written communications listed on Annex A hereto. 
 2. Purchase and Resale of the
Securities. 
 (a)    The Partnership agrees to issue and sell the Securities to the several Initial Purchasers as
provided in this Agreement, and each Initial Purchaser, on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, agrees, severally and not jointly, to purchase from the
Partnership the respective principal amount of Securities set forth opposite such Initial 

  
 2 

 
Purchaser’s name in Schedule 1 hereto at a price equal to (i) in the case of the 2029 Notes, 99.0% of the principal amount thereof and (ii) in the case of the 2031 Notes, 99.0% of
the principal amount thereof, in each case, plus accrued interest, if any, from January 8, 2021 to the Closing Date (as defined below). The Partnership will not be obligated to deliver any of the Securities except upon payment for all the
Securities to be purchased as provided herein. 
 (b)    The Partnership understands that the Initial Purchasers intend
to offer the Securities for resale on the terms set forth in the Time of Sale Information. Each Initial Purchaser, severally and not jointly, represents, warrants and agrees that: 

(i)    it is a qualified institutional buyer within the meaning of Rule 144A under the Securities Act (a
“QIB”) and an accredited investor within the meaning of Rule 501(a) of Regulation D under the Securities Act (“Regulation D”); 

(ii)    it has not solicited offers for, or offered or sold, and will not solicit offers for, or offer or
sell, the Securities by means of any form of general solicitation or general advertising within the meaning of Rule 502(c) of Regulation D or in any manner involving a public offering within the meaning of Section 4(a)(2) of the Securities Act;
and 
 (iii)    it has not solicited offers for, or offered or sold, and will not solicit offers for, or
offer or sell, the Securities as part of their initial offering except: 
 (A)    to persons whom it
reasonably believes to be QIBs in transactions pursuant to Rule 144A under the Securities Act (“Rule 144A”) and in connection with each such sale, it has taken or will take reasonable steps to ensure that the purchaser of the Securities is
aware that such sale is being made in reliance on Rule 144A; or 
 (B)    in accordance with the
restrictions set forth in Annex C hereto. 
 (c)    Each Initial Purchaser acknowledges and agrees that the Partnership
and, for purposes of the “no registration” opinions to be delivered to the Initial Purchasers pursuant to Sections 6(f) and 6(g) hereof, counsel for the Partnership and counsel for the Initial Purchasers, respectively, may rely upon the
accuracy of the representations and warranties of the Initial Purchasers, and compliance by the Initial Purchasers with their agreements, contained in paragraph (b) above (including Annex C hereto), and each Initial Purchaser hereby consents to
such reliance. 
 (d)    The Partnership acknowledges and agrees that the Initial Purchasers may offer and sell
Securities to or through any affiliate of an Initial Purchaser and that any such affiliate may offer and sell Securities purchased by it to or through any Initial Purchaser. 

(e)    Payment for and delivery of the Securities will be made at the offices of Simpson Thacher & Bartlett LLP
at 10:00 A.M., New York City time, on January 8, 2021, 

  
 3 

 
or at such other time or place on the same or such other date, not later than the fifth business day thereafter, as the Representative and the Partnership may agree upon in writing. The time and
date of such payment and delivery is referred to herein as the “Closing Date.” 
 (f)    Payment for
the Securities shall be made by wire transfer in immediately available funds to the account(s) specified by the Partnership to the Representative against delivery to the nominee of The Depository Trust Company (“DTC”), for the
account of the Initial Purchasers, of one or more global notes representing the Securities (collectively, the “Global Note”), with any transfer taxes payable in connection with the sale of the Securities duly paid by the
Partnership. An electronic copy of the Global Note will be made available for inspection by the Representative not later than 1:00 P.M., New York City time, on the business day prior to the Closing Date. 

(g)    The Partnership acknowledges and agrees that each Initial Purchaser is acting solely in the capacity of an
arm’s length contractual counterparty to the Partnership with respect to the offering of Securities contemplated hereby (including in connection with determining the terms of the offering) and not as a financial advisor or a fiduciary to, or an
agent of, the Partnership or any other person. Additionally, neither the Representative nor any other Initial Purchaser is advising the Partnership or any other person as to any legal, tax, investment, accounting or regulatory matters in any
jurisdiction. The Partnership shall consult with its own advisors concerning such matters and shall be responsible for making its own independent investigation and appraisal of the transactions contemplated hereby, and the Initial Purchasers shall
have no responsibility or liability to the Partnership with respect thereto. Any review by the Representative or any Initial Purchaser of the Partnership and the transactions contemplated hereby or other matters relating to such transactions will be
performed solely for the benefit of the Representative or such Initial Purchaser, as the case may be, and shall not be on behalf of the Partnership or any other person. 

3. Representations and Warranties of the Partnership. The Partnership represents and warrants, and Equitrans represents and warrants
solely as to Sections 3(c), 3(d)(ii), 3(i), 3(v)(ii), 3(gg)(ii), 3(hh), 3(ii), 3(yy) and 3(zz), to each Initial Purchaser that: 

(a)    Preliminary Offering Memorandum, Time of Sale Information and Offering Memorandum. The Preliminary
Offering Memorandum, as of its date, did not, the Time of Sale Information, at the Time of Sale, did not, and on the Closing Date, will not, and the Offering Memorandum, in the form first used by the Initial Purchasers to confirm sales of the
Securities and as of the Closing Date, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not
misleading; provided that the Partnership makes no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating to any Initial Purchaser furnished to the Partnership
in writing by such Initial Purchaser through the Representative expressly for use in the Preliminary Offering Memorandum, the Time of Sale Information or the Offering Memorandum. 

  
 4 

 (b)    Additional Written Communications. The Partnership
(including its agents and representatives, other than the Initial Purchasers in their capacity as such) has not prepared, made, used, authorized, approved or referred to and will not prepare, make, use, authorize, approve or refer to any written
communication that constitutes an offer to sell or solicitation of an offer to buy the Securities (each such communication by the Partnership or its agents and representatives (other than a communication referred to in clauses (i) and (ii)
below) an “Issuer Written Communication”) other than (i) the Preliminary Offering Memorandum, (ii) the Offering Memorandum, (iii) the documents listed on Annex A hereto, including a term sheet substantially in the
form of Annex B hereto, which constitute part of the Time of Sale Information, and (iv) any electronic road show or other written communications, in each case used in accordance with Section 4(c) hereof. Each such Issuer Written
Communication, when taken together with the Time of Sale Information at the Time of Sale, did not, and on the Closing Date will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading; provided that the Partnership makes no representation or warranty with respect to any statements or omissions made in each such Issuer Written
Communication in reliance upon and in conformity with information relating to any Initial Purchaser furnished to the Partnership in writing by such Initial Purchaser through the Representative expressly for use in any Issuer Written
Communication.
 (c)    Incorporated Documents. The documents incorporated by reference in each of the
Time of Sale Information and the Offering Memorandum, when they were filed with the Securities and Exchange Commission (the “Commission”), conformed or will conform, as the case may be, in all material respects to the requirements
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules and regulations of the Commission promulgated thereunder, and did not and will not contain any untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. 

(d)    Financial Statements. (i) The historical financial statements and schedules of the Partnership
and its subsidiaries included in or incorporated by reference in the Time of Sale Information and the Offering Memorandum present fairly the financial condition, results of operations and cash flows of the Partnership as of the dates and for the
periods indicated, comply as to form with the applicable accounting requirements of the Securities Act and have been prepared in conformity with United States generally accepted accounting principles (“GAAP”) applied on a consistent basis
throughout the periods involved (except as otherwise noted therein). The other financial information of the Partnership Entities, including non-GAAP financial measures, if any, contained in the Time of Sale
Information and the Offering Memorandum has been derived from the accounting records of the Partnership Entities and fairly presents in all material respects the information purported to be shown thereby. The interactive data in eXtensible Business
Reporting Language included or incorporated by reference in each of the Preliminary Offering Memorandum, the Time of Sale Information and the Offering Memorandum fairly presents the information called for in all material respects and is prepared in
accordance with the Commission’s rules and guidelines applicable thereto. 

  
 5 

 (ii) The historical financial statements and schedules of Equitrans and its subsidiaries
included in or incorporated by reference in the Time of Sale Information and the Offering Memorandum present fairly the financial condition, results of operations and cash flows of Equitrans as of the dates and for the periods indicated, comply as
to form with the applicable accounting requirements of the Securities Act and have been prepared in conformity with GAAP applied on a consistent basis throughout the periods involved (except as otherwise noted therein). The other financial
information of Equitrans, including non-GAAP financial measures, if any, contained in the Time of Sale Information and the Offering Memorandum has been derived from the accounting records of Equitrans and
fairly presents in all material respects the information purported to be shown thereby. The interactive data in eXtensible Business Reporting Language included or incorporated by reference in each of the Preliminary Offering Memorandum, the Time of
Sale Information and the Offering Memorandum fairly presents the information called for in all material respects and is prepared in accordance with the Commission’s rules and guidelines applicable thereto. 

(e)    No Material Adverse Change. Since the date of Equitrans’ latest audited financial statements
included in or incorporated by reference in the Time of Sale Information and the Offering Memorandum, none of the Partnership Entities has sustained any loss or interference with its business from fire, explosion, flood or other calamity, whether or
not covered by insurance, or from any labor dispute or court or governmental action, investigation, order or decree, otherwise than as set forth or contemplated in the Time of Sale Information and the Offering Memorandum and other than as would not
reasonably be likely to have a Material Adverse Effect (as defined below). Subsequent to the respective dates as of which information is given in the Time of Sale Information and the Offering Memorandum, in each case excluding any amendments or
supplements to the foregoing made after the execution of this Agreement, there has not been (i) any material adverse change, or any development involving, individually or in the aggregate, a prospective material adverse change, in or affecting
the condition (financial or otherwise), management, earnings, business or properties of the Partnership Entities taken as a whole, whether or not arising from transactions in the ordinary course of business, except as described in the Time of Sale
Information and the Offering Memorandum (exclusive of any supplement thereto) or (ii) any dividend or distribution of any kind declared, paid or made by any Partnership Entity, in each case other than as described in the Time of Sale
Information and the Offering Memorandum. 
 (f)    Organization and Good Standing. Each of the Partnership
Entities has been duly formed or incorporated and is validly existing as a limited partnership, limited liability company or corporation, as applicable, in good standing under the laws of its jurisdiction of organization with all requisite power and
authority, in the case of the Partnership, to enter into and perform its obligations under this Agreement. Each of the Partnership Entities has all requisite power and authority to own or lease and to operate its properties currently owned or leased
or to be owned or leased on the Closing Date 

  
 6 

 
and conduct its business as currently conducted or to be conducted on the Closing Date, in each case, as described in the Time of Sale Information and the Offering Memorandum, and is duly
qualified to do business as a foreign corporation, limited partnership or limited liability company, as applicable, and is in good standing under the laws of each jurisdiction which requires, or on the Closing Date will require, such qualification,
except where the failure to be so qualified, in good standing or have such power or authority would not, individually or in the aggregate, reasonably be likely to have a material adverse effect on the condition (financial or otherwise), prospects,
earnings, business or properties of the Partnership Entities, taken as a whole or on the performance by the Partnership of its obligations under this Agreement and the Securities (a “Material Adverse Effect”) or subject the limited
partners of the Partnership to any material liability or disability. 
 (g)    Power and Authority of General
Partner. The General Partner, an indirect wholly owned subsidiary of Equitrans, has, and on the Closing Date will have, all requisite power and authority to act as general partner of the Partnership in all material respects as described in the
Time of Sale Information and the Offering Memorandum. 
 (h)    Ownership of General Partner Interest. The
General Partner is, and after giving effect to the transactions contemplated by this Agreement will be, the sole general partner of the Partnership. As of the date of this Agreement, the General Partner owns all of the
non-economic general partner interest in the Partnership (the “General Partner Interest”); such General Partner Interest has been, and on the Closing Date will be, duly authorized and validly
issued in accordance with the agreement of limited partnership of the Partnership (as amended, the “Partnership Agreement”); and the General Partner owns, and on the Closing Date will own, such General Partner Interest free and
clear of all liens, encumbrances, security interests, pledges, mortgages or restrictions on transfer (“Liens”), except for restrictions on transferability contained in the Partnership Agreement or as described in the Time of Sale
Information and the Offering Memorandum. 
 (i)    Capitalization. Equitrans has the capitalization as set forth
in each of the Time of Sale Information and the Offering Memorandum under the heading “Capitalization” in the column marked “Historical (unaudited)”; and the Partnership is an indirect, wholly owned subsidiary of Equitrans. 

(j)    Ownership of Certain Partnership Entities and the MVP Joint Venture. 

(i)    The Partnership owns all of the membership interests of Equitrans Investments, LLC, a Delaware
limited liability company (“Equitrans Investments”); all of such equity interests have been duly authorized and validly issued in accordance with the applicable Organizational Documents, and are fully paid (to the extent required by the
applicable Organizational Documents) and nonassessable (except as such nonassessability may be affected by Sections 18-607 and 18-804 of the Delaware Limited Liability
Company Act (the “Delaware LLC Act”)); and the Partnership owns such equity interests free and clear of all Liens except for restrictions on transferability contained in the applicable Organizational Documents of Equitrans Investments
or as described in the Time of Sale Information and the Offering Memorandum; 

  
 7 

 (ii)     The Partnership owns all of the membership
interests in MVP Holdco, LLC, a Delaware limited liability company (“MVP Holdco”); all of such equity interests have been duly authorized and validly issued in accordance with the applicable Organizational Documents, are fully paid
(to the extent required by the applicable Organizational Documents) and nonassessable (except as such nonassessability may be affected by, as applicable, Sections 18-607 and
18-804 of the Delaware LLC Act), and such equity interests are owned free and clear of all Liens except for restrictions on transferability contained in the applicable Organizational Documents or as described
in the Time of Sale Information and the Offering Memorandum; 
 (iii)    MVP Holdco owns membership
interests in Mountain Valley Pipeline, LLC, a Delaware series limited liability company and joint venture with certain third parties (“MVP Joint Venture”); all of such equity interests have been duly authorized and validly issued in
accordance with the limited liability company agreement of MVP Joint Venture, as amended from time to time (the “MVP Joint Venture LLC Agreement”), are fully paid (to the extent required by the MVP Joint Venture LLC Agreement) and
nonassessable (except as provided in the MVP Joint Venture LLC Agreement and as such nonassessability may be affected by, as applicable, Sections 18-607 and 18-804 of
the Delaware LLC Act), and such equity interests are owned free and clear of all Liens except for restrictions on transferability contained in the MVP Joint Venture LLC Agreement or as described in the Time of Sale Information and the Offering
Memorandum; 
 (iv)    The Partnership owns all of the membership interests in EQM Gathering Holdings,
LLC, a Delaware limited liability company (“EQM Gathering”); all of such equity interests have been duly authorized and validly issued in accordance with the applicable Organizational Documents, are fully paid (to the extent
required by the applicable Organizational Documents) and nonassessable (except as such nonassessability may be affected by, as applicable, Sections 18-607 and 18-804 of
the Delaware LLC Act), and such equity interests are owned free and clear of all Liens except for restrictions on transferability contained in the applicable Organizational Documents or as described in the Time of Sale Information and the
Offering Memorandum; 
 (v)    EQM Gathering owns membership interests in Eureka Midstream Holdings, LLC,
a Delaware limited liability company and joint venture with a certain third party (“Eureka Joint Venture”); all of such equity interests have been duly authorized and validly issued in accordance with the limited liability company
agreement of Eureka Joint Venture, as amended from time to time (the “Eureka Joint Venture LLC Agreement”), are fully paid (to the extent required by the Eureka Joint Venture LLC Agreement) and nonassessable (except as provided in
the Eureka Joint Venture LLC Agreement and as such nonassessability may be affected by, as applicable, Sections 18-607 and 18-804 of the Delaware LLC

  
 8 

 
Act), and such equity interests are owned free and clear of all Liens except for restrictions on transferability contained in the Eureka Joint Venture LLC Agreement or as described in the Time of
Sale Information and the Offering Memorandum; 
 (vi)    Eureka Joint Venture owns, directly or
indirectly, 100% of the equity interests in Eureka Midstream, LLC, Eureka Services, LLC, Eureka Services Intermediate, LLC and Eureka Land, LLC (collectively with the Eureka Joint Venture, the “Eureka Entities”); all of such equity
interests have been duly authorized and validly issued in accordance with the certificate of formation and limited liability company agreement of the applicable Eureka Entity, are fully paid (to the extent required by the certificate of formation
and limited liability company agreement of the applicable Eureka Entity) and nonassessable (except as such nonassessability may be affected by, as applicable, Sections 18-607 and
18-804 of the Delaware LLC Act), and such equity interests are owned free and clear of all Liens except for (A) restrictions on transferability contained in the Eureka Joint Venture LLC Agreement and the
certificate of formation and the limited liability company agreement of the applicable Eureka Entity or as described in the Time of Sale Information and the Offering Memorandum and (B) Liens created or arising under that certain Amended and
Restated Credit Agreement, dated as of August 25, 2017, by and among Eureka Midstream, LLC, as Borrower, ABN AMRO Capital USA LLC, as Administrative Agent and certain financial institutions, as lenders thereto (as amended and modified from time
to time, the “Eureka Credit Agreement”); 
 (vii)    Other than as described above, the
Partnership wholly owns, directly or indirectly, each of the entities listed on Schedule 2 hereof. 
 (k)    No
Other Subsidiaries. Other than (i) the General Partner’s ownership of the General Partner Interest, (ii) the Partnership’s direct or indirect ownership of equity interests in the entities set forth on Schedule 2
hereto and the Eureka Entities, (iii) MVP Holdco’s membership interests in MVP Joint Venture and (iv) the Partnership’s ownership of Class B limited liability company interests in EQT Energy Supply, LLC, none of the
Partnership Entities own or will own, at the Time of Delivery, directly or indirectly, any equity or long-term debt securities (for the avoidance of doubt, such long-term debt securities shall not include any intercompany loan between or among
Equitrans, the Partnership or their respective subsidiaries) of any corporation, partnership, limited liability company, joint venture, association or other entity. 

(l)    Due Authorization. The Partnership has all requisite power and authority to execute and deliver this
Agreement, the Securities and the Indenture (collectively, the “Transaction Documents”) and perform its obligations hereunder and thereunder. The Partnership has all requisite partnership power and authority to issue, sell and
deliver the Securities, in accordance with and upon the terms and conditions set forth in this Agreement, the Partnership Agreement, the Time of Sale Information and the Offering Memorandum. On the Closing Date, all limited partnership action
required to be taken by the Partnership or any of its partners for the authorization, issuance, sale and 

  
 9 

 
delivery of the Securities, the execution and delivery by the Partnership of the Transaction Documents and the consummation of the transactions contemplated hereby and thereby, shall have been
validly taken. 
 (m)    Organizational Documents. Each of the Partnership Agreement and the GP LLC Agreement has
been duly authorized and validly executed and delivered by the parties thereto and is a valid and legally binding agreement of such parties thereto, enforceable against such parties in accordance with their respective terms; provided that,
with respect to each such agreement, the enforceability thereof may be limited by (A) bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium or similar laws relating to or affecting creditors’ rights generally and by
general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or law) and (B) public policy, any applicable law relating to fiduciary duties and indemnification and an implied covenant of good
faith and fair dealing (clauses (A) and (B) collectively, the “Enforceability Exceptions”). 

(n)    The Indenture. The Indenture has been duly authorized by the Partnership and, when executed and delivered by
the Partnership and the Trustee, will constitute a valid and binding agreement of the Partnership, enforceable against the Partnership in accordance with its terms, subject to the Enforceability Exceptions. 

(o)    The Securities. The Securities have been duly authorized by the Partnership and, when duly executed,
authenticated, issued and delivered as provided in the Indenture and paid for as provided herein, will be duly and validly issued and outstanding and will constitute valid and legally binding obligations of the Partnership enforceable against the
Partnership in accordance with their terms, subject to the Enforceability Exceptions, and will be entitled to the benefits of the Indenture. 

(p)    Purchase Agreement. This Agreement has been duly authorized, executed and delivered by the Partnership. 

(q)    Descriptions of the Transaction Documents. Each Transaction Document conforms in all material respects to
the description thereof contained in each of the Time of Sale Information and the Offering Memorandum. 
 (r)    No
Violation or Default. None of the Partnership Entities, or to the knowledge of the Partnership, the Eureka Entities, are in violation, breach or default (or, with the giving of notice or lapse of time, would be in violation, breach or default)
of (i) any provision of its Organizational Documents, (ii) the terms of any indenture, contract, lease, mortgage, deed of trust, note agreement, loan agreement or other agreement, obligation, condition, covenant or instrument to which any
of the Partnership Entities is a party relating to the Assets or the operation thereof or (iii) any statute, law, rule, regulation, judgment, order or decree of any court, governmental, regulatory or administrative authority, agency or body,
arbitrator or other authority having jurisdiction over any of the Partnership Entities or any of their respective properties, as applicable, except, in the case of clauses (ii) and (iii), where such breaches, violations, defaults or Liens,
individually or in the aggregate, would not reasonably be likely to have a Material Adverse Effect. 

  
 10 

 (s)    No Conflicts. None of (i) the offering, issuance or
sale by the Partnership of the Securities, (ii) the execution, delivery and performance of the Transaction Documents by the Partnership, or (iii) the application of the proceeds as described under the caption “Use of Proceeds” in
the Time of Sale Information and the Offering Memorandum (A) conflicts or will conflict with or constitutes or will constitute a violation of the Organizational Documents of any of the Partnership Entities, (B) conflicts or will conflict
with or constitutes or will constitute a breach or violation of, or a default (or an event that, with notice or lapse of time or both, would constitute such a default) under, or will result in the creation or imposition of any Lien upon any property
or assets of the Partnership Entities under, any indenture, mortgage, deed of trust, loan agreement, lease or other agreement or instrument to which any of the Partnership Entities is a party or by which any of them or any of their respective
properties may be bound or (C) violates or will violate any statute, law or regulation or any order, judgment, decree or injunction of any court or governmental agency or body having jurisdiction over any of the Partnership Entities or any of
their properties in a proceeding to which any of them or their property is a party, except, in the case of clauses (B) and (C), where such breaches, violations, defaults or Liens would not, individually or in the aggregate, reasonably be likely
to have a Material Adverse Effect. 
 (t)    No Consents Required. No permit, consent, approval, authorization,
order, registration, filing or qualification of or with any court, governmental agency or body having jurisdiction over any of the Partnership Entities or any of their properties or assets is required in connection with (i) the offering,
issuance or sale by the Partnership of the Securities, (ii) the execution, delivery and performance of the Transaction Documents by the Partnership, (iii) the consummation of the transactions contemplated by the Transaction Documents by
the Partnership or (iv) the application of the proceeds as described under the caption “Use of Proceeds” in the Time of Sale Information and the Offering Memorandum, other than (A) any necessary qualification under the securities
or blue sky laws of the various jurisdictions in which the Securities are being offered by the Initial Purchasers, (B) consents that have been, or prior to the Closing Date will be, obtained and (C) consents that, if not obtained, would
not reasonably be likely to have a Material Adverse Effect or materially impair the ability of the Partnership to perform their respective obligations under the Transaction Documents. 

(u)    Legal Proceedings. Except as described in the Time of Sale Information and the Offering Memorandum, no
action, suit, proceeding or inquiry by or before any court or governmental or other regulatory or administrative agency, authority or body or any arbitrator involving any of the Partnership Entities or their property or, to the knowledge of the
Partnership, the Eureka Entities or their property is pending or, to the knowledge of the Partnership, threatened or contemplated, that would reasonably be likely to have, individually or in the aggregate, a Material Adverse Effect. 

(v)    Independent Accountants. (i) Ernst & Young LLP, who have certified certain financial
statements of the Partnership and its subsidiaries (including the related 

  
 11 

 
notes thereto) included in or incorporated by reference in the Time of Sale Information and the Offering Memorandum are independent public accountants with respect to the Partnership and its
subsidiaries within the applicable rules and regulations adopted by the Commission and the Public Company Accounting Oversight Board (United States) and as required by the Securities Act. 

(ii) Ernst & Young LLP, who have certified certain financial statements of Equitrans and its subsidiaries (including the related
notes thereto) included in or incorporated by reference in the Time of Sale Information and the Offering Memorandum are independent public accountants with respect to Equitrans and its subsidiaries within the applicable rules and regulations adopted
by the Commission and the Public Company Accounting Oversight Board (United States) and as required by the Securities Act. 

(w)    Title to Real and Personal Property. On the Closing Date, except as described in the Time of Sale
Information and the Offering Memorandum or except to the extent that failure of the following to be true, individually or in the aggregate, would not reasonably be likely to have a Material Adverse Effect: 

(i)    the Partnership Entities will have (A) good and indefeasible title to all real property
(exclusive of rights-of-way, as hereinafter defined) owned by them and (B) good title to all personal property owned by them, in each of cases (A) and
(B) as such properties are described in the Time of Sale Information or the Offering Memorandum, free and clear of all Liens, subject to Liens created or arising under the Eureka Credit Agreement; and 

(ii)     all land, buildings and other improvements, and all equipment and other personal property, to
be held under lease or sublease by any of the Partnership Entities, will be held by them under valid and subsisting leases or subleases, as the case may be, with such exceptions as do not materially interfere with the use made or proposed to be made
of such property, buildings or other improvements by the Partnership Entities, as such uses are described in the Time of Sale Information or the Offering Memorandum. 

(x)     Intellectual Property. Except (i) as described in each of the Time of Sale Information and
Offering Memorandum or (ii) as would not reasonably be expected to, individually or in the aggregate, have a Material Adverse Effect, (A) the Partnership Entities own, possess, license or have other rights to use, on reasonable terms, all
patents, patent applications, trade and service marks, trade and service mark registrations, trade names, copyrights, licenses, inventions, trade secrets, technology, know-how and other intellectual property
(collectively, the “Intellectual Property”) necessary for the operations of the Assets as now conducted or as proposed in the Time of Sale Information and the Offering Memorandum to be conducted, and (B) the Partnership
Entities’ conduct of their respective businesses does not infringe, misappropriate or otherwise violate the Intellectual Property of any person. 

  
 12 

 (y)    No Undisclosed Relationships. No relationship, direct or
indirect, exists between or among any Partnership Entity, on the one hand, and the directors, officers, unitholders, stockholders, affiliates, customers or suppliers of any Partnership Entity, on the other hand, that would be required by the
Securities Act to be described in a registration statement on Form S-1 to be filed with the Commission and that is not so described in each of the Time of Sale Information and the Offering Memorandum. 

(z)    Investment Company Act. The Partnership is not, and immediately following the sale of the Securities
to be sold by the Partnership hereunder and application of the net proceeds from such sale as described in the Time of Sale Information and the Offering Memorandum under the caption “Use of Proceeds,” will not be, an “investment
company” or a company “controlled by” an “investment company” within the meaning of the Investment Company Act of 1940, as amended. 

(aa)    Taxes. Each of the Partnership Entities has filed all foreign, federal, state and local tax returns
that are required to be filed or has requested extensions thereof, other than certain state and local tax returns as to which the failure to file would not reasonably be likely to have, individually or in the aggregate, a Material Adverse Effect,
and has timely paid all taxes shown to be due pursuant to such returns other than (i) those currently being contested in good faith for which adequate reserves have been established or (ii) those which, if not paid, would not reasonably be
likely to have a Material Adverse Effect. 
 (bb)    Rights of Way. Each of the Partnership Entities has, and on
the Closing Date will have, such consents, easements, rights-of-way or licenses from any person (collectively, “rights-of-way”) as are necessary to conduct its business in the manner described in the Time of Sale Information and the Offering Memorandum, subject to such qualifications as may be set forth in the
Time of Sale Information and the Offering Memorandum, except for such rights-of-way the failure of which to obtain would not reasonably be likely to have, individually
or in the aggregate, a Material Adverse Effect; and each of the Partnership Entities will have fulfilled and performed all of its obligations with respect to such
rights-of-way and no event shall have occurred that allows, or after notice or lapse of time would allow, revocation or termination thereof or would result in any
impairment of the rights of the holder of any such rights-of-way except for such revocations, terminations and impairments that would not reasonably be likely to have a
Material Adverse Effect. 
 (cc)    Licenses and Permits. Each of the Partnership Entities possesses, and on the
Closing Date will possess, such permits, licenses, patents, certificates of need, approvals, consents and other authorizations issued by the appropriate federal, state, local or foreign governments or regulatory agencies or bodies (collectively,
“Governmental Licenses”) necessary to conduct its business in the manner described in the Time of Sale Information and the Offering Memorandum except for such Governmental Licenses, the failure of which to obtain would not,
individually or in the aggregate, reasonably be likely to have a Material Adverse Effect; the Partnership Entities are and will be in compliance with the terms and conditions of all such Governmental Licenses, except where the failure to so comply
would not, individually or 

  
 13 

 
in the aggregate, reasonably be likely to have a Material Adverse Effect; the Governmental Licenses are and will be valid and in full force and effect, except where the invalidity of such
Governmental Licenses or the failure of such Governmental Licenses to be in full force and effect would not, individually or in the aggregate, reasonably be likely to have a Material Adverse Effect; and to the knowledge of the Partnership, none of
the Partnership Entities has received any notice of proceedings relating to the revocation or modification of any Governmental Licenses that, individually or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would
reasonably be likely to have a Material Adverse Effect. 
 (dd)    No Labor Disputes. No labor problem or
dispute with the employees of any of the Partnership Entities exists or, to the knowledge of the Partnership, is threatened, that would reasonably be likely to have a Material Adverse Effect. 

(ee)    Certain Environmental Matters. Except as described in the Time of Sale Information and the Offering
Memorandum or except as would not, individually or in the aggregate, reasonably be likely to have a Material Adverse Effect: 

(i)    none of the Partnership Entities is in violation of any federal, state, local or foreign statute,
law, rule, regulation, ordinance, code, policy or rule of common law or any judicial or administrative interpretation thereof, including any judicial or administrative order, consent, decree or judgment, relating to protection of the
environment, human health (to the extent relating to exposure to Hazardous Materials) or wildlife, or to pollution or contamination of the environment (including, without limitation, ambient air, surface water, groundwater, land surface or
subsurface strata), including, without limitation, laws and regulations relating to the release or threatened release of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous substances, petroleum or petroleum products
(collectively, “Hazardous Materials”) or to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials (collectively, “Environmental Laws”); 

(ii)    the Partnership Entities have, and on the Closing Date will have, all permits, authorizations and
approvals required under any applicable Environmental Laws for the ownership and operation of the Assets and to conduct their respective businesses in the manner described in the Time of Sale Information and the Offering Memorandum and are each in
compliance with their requirements; 
 (iii)    none of the Partnership Entities have received written
notice of any pending or threatened administrative, regulatory or judicial actions, suits, demands, demand letters, claims, liens, notices of noncompliance or violation, investigation or proceedings relating to any Environmental Law against any of
the Partnership Entities; and 
 (iv)    the Partnership is not aware of any event or circumstance that
might reasonably be expected to form the basis of an order for clean-up or 

  
 14 

 
remediation, or an action, suit or proceeding by any private party or governmental body or agency, against or affecting any of the Partnership Entities relating to Hazardous Materials or any
Environmental Laws. 
 In the ordinary course of their business, the Partnership Entities periodically review the effect of Environmental
Laws on their business, operations and properties, in the course of which they identify and evaluate associated costs and liabilities (including, without limitation, any capital or operating expenditures required for
clean-up, closure of properties or compliance with Environmental Laws, or any permit, license or approval, any related constraints on operating activities and any potential liabilities to third parties). On
the basis of such review, the Partnership Entities have concluded that such associated costs and liabilities would not, individually or in the aggregate, reasonably be likely to have a Material Adverse Effect. 

(ff)    Compliance with ERISA. Except as would not, individually or in the aggregate, reasonably be likely
to have a Material Adverse Effect, (i) the Partnership Entities are in compliance in all material respects with all presently applicable provisions of the Employee Retirement Income Security Act of 1974, as amended, including the regulations
and published governmental interpretations thereunder (“ERISA”); (ii) no “reportable event” (as defined in Section 4043(c) ERISA) has occurred or is reasonably likely to occur with respect to any “pension
plan” (as defined in Section 3(2) of ERISA) for which any Partnership Entity or any member of such Partnership Entity’s “Controlled Group” (defined as any entity, whether or not incorporated, that is under common control
with such Partnership Entity within the meaning of Section 4001(a)(14) of ERISA or any entity that would be regarded as a single employer with such Partnership Entity under Section 414(b), (c), (m) or (o) of the Internal Revenue Code
of 1986, as amended, including the regulations and published governmental interpretations thereunder (the “Code”)) has any liability, excluding any reportable event for which a waiver could apply; (iii) no Partnership Entity
nor any member of such Partnership Entity’s Controlled Group has incurred, nor will any such entity expect to incur, liability under (a) Title IV of ERISA with respect to termination of, or withdrawal from, any “pension plan” or
(b) Sections 412 or 4971 of the Code with respect to any “pension plan”; (iv) each “pension plan” for which any Partnership Entity or any member of such Partnership Entity’s Controlled Group has any liability that is
intended to be qualified under Section 401(a) of the Code is the subject of a favorable determination or opinion letter from the Internal Revenue Service to the effect that it is so qualified and, to the knowledge of the Partnership, nothing
will have occurred, whether by action or by failure to act, which could reasonably be expected to cause the loss of such qualification; and (v) no Partnership Entity or any member of any Partnership Entities’ Controlled Group has incurred
any unpaid liability to the Pension Benefit Guaranty Corporation (other than for payment of premiums in the ordinary course of business) for which such Partnership Entity or any member of such Controlled Group would reasonably be expected to be
liable. 
 (gg)    Description of Contracts. The information incorporated by reference into the Time of Sale
Information and the Offering Memorandum from (i) the Partnership’s annual report on Form 10-K for the year ended December 31, 2019 under the captions

  
 15 

 
“Business—Regulatory Environment” and “Certain Relationships and Related Transactions and Director Independence” and (ii) Equitrans’ annual report on Form 10-K for the year ended December 31, 2019 under the captions “Business—Regulatory Environment” and “Certain Relationships and Related Transactions and Director Independence,” in each
case to the extent that it constitutes matters of law, summaries of legal matters, summaries of provisions of the Organizational Documents or any other instruments or agreements, summaries of legal proceedings, or legal conclusions, is correct in
all material respects; all descriptions in the Time of Sale Information and the Offering Memorandum of any of the terms of any indenture, contract, lease, mortgage, deed of trust, note agreement, loan agreement or other agreement, obligation,
condition, covenant or instrument to which any of the Partnership Entities or the Eureka Entities is a party are accurate in all material respects. 

(hh)    Disclosure Controls. Equitrans has established and maintains “disclosure controls and procedures”
(as is defined in Rule 13a-15(e) under the Exchange Act); and (i) such disclosure controls and procedures are designed to ensure that the information required to be disclosed by Equitrans in the
reports it files or will file or submit under the Exchange Act, as applicable, is accumulated and communicated to Equitrans’ management, including its principal executive officer and principal financial officer, as appropriate, to allow timely
decisions regarding required disclosure to be made and (ii) such disclosure controls and procedures are effective in all material respects to perform the functions for which they were established to the extent required by Rule 13a-15 of the Exchange Act. 
 (ii)    Accounting Controls. Equitrans
maintains systems of “internal control over financial reporting” (as defined in Rule 13a-15(f) of the Exchange Act) that comply with the requirements of the Exchange Act and have been designed by, or
under the supervision of, its principal executive and principal financial officers, or persons performing similar functions, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with GAAP, including, but not limited to, internal controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific
authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain accountability for its assets; (iii) access to assets is permitted only in accordance with
management’s general or specific authorization; and (iv) the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any differences. As of the date
hereof, there are no material weaknesses or significant deficiencies in Equitrans’ internal controls. 

(jj)    Insurance. The Partnership Entities are, and on the Closing Date will be, insured by insurers of recognized
financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which they are engaged; all policies of insurance and any fidelity or surety bonds insuring the Partnership Entities or
their respective businesses, assets, employees, officers and directors will be in full force and effect; and the Partnership Entities will be in compliance with the terms of such policies and instruments in all material respects. 

  
 16 

 (kk)    No Unlawful Payments. No Partnership Entity nor, to the
knowledge of the Partnership, any director, officer, agent, employee or affiliate of any Partnership Entity, has (i) used any funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to political activity;
(ii) made or taken an act in furtherance of an offer, promise or authorization of any direct or indirect unlawful payment or benefit to any foreign or domestic government or regulatory official or employee, including of any government-owned or
controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf of any of the foregoing, or any political party or party official or candidate for political office; (iii) violated or is
in violation of any provision of the Foreign Corrupt Practices Act of 1977, as amended, or any applicable law or regulation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, or
committed an offence under the Bribery Act 2010 of the United Kingdom, or any other applicable anti-bribery or anti-corruption laws; or (iv) made, offered, agreed, requested or taken an act in furtherance of any unlawful bribe or other unlawful
benefit, including, without limitation, any rebate, payoff, influence payment, kickback or other unlawful or improper payment or benefit. The Partnership Entities and, to the knowledge of the Partnership, their affiliates have instituted, and
maintain and enforce, policies and procedures designed to promote and ensure compliance with all applicable anti-bribery and anti-corruption laws. 

(ll)    Compliance with Anti-Money Laundering Laws. The operations of the Partnership Entities are and have been
conducted at all times in compliance with applicable financial recordkeeping and reporting requirements, including those of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the applicable money laundering statutes of all
jurisdictions where the Partnership Entities conduct business, the rules and regulations thereunder and any related or similar rules, regulations or guidelines issued, administered or enforced by any governmental or regulatory agency (collectively,
the “Anti-Money Laundering Laws”) and no action, suit or proceeding by or before any court or governmental or regulatory agency, authority or body or any arbitrator involving any Partnership Entity with respect to the Anti-Money
Laundering Laws is pending or, to the knowledge of the Partnership, threatened. 
 (mm)    No Conflicts with
Sanctions Laws. No Partnership Entity nor, to the knowledge of the Partnership, any director, officer, employee or affiliate of any Partnership Entity, is currently the subject or the target of any sanctions administered or enforced by the U.S.
Government (including, without limitation, the Office of Foreign Assets Control of the U.S. Department of the Treasury or the U.S. Department of State and including, without limitation, the designation as a “specially designated national”
or “blocked person”), the United Nations Security Council, the European Union, Her Majesty’s Treasury, or other relevant sanctions authority (collectively, “Sanctions”), nor is any Partnership Entity located,
organized or resident in a country or territory that is the subject or the target of Sanctions, including, without limitation, Cuba, Iran, North Korea, Syria and the Crimea region of Ukraine (each, a “Sanctioned Country”); and the
Partnership Entities will not directly or indirectly use the proceeds of the offering of the Securities hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity (i)
to fund or facilitate any 

  
 17 

 
activities of or business with any person that, at the time of such funding or facilitation, is the subject or the target of Sanctions, (ii) to fund or facilitate any activities of or
business in any Sanctioned Country or (iii) in any other manner that will result in a violation by any person (including any person participating in the transaction, whether as initial purchaser, advisor, investor or otherwise) of Sanctions.
For the past five years, the Partnership Entities have not knowingly engaged in and are not now knowingly engaged in any dealings or transactions with any person that at the time of the dealing or transaction is or was the subject or the target of
Sanctions or with any Sanctioned Country. 
 (nn)    No Restrictions on Subsidiaries. Except as disclosed in each
of the Time of Sale Information and the Offering Memorandum or as restricted by that certain Third Amended and Restated Credit Agreement, dated as of October 31, 2018, by and among the Partnership, Wells Fargo Bank, National Association, as
Administrative Agent, Swing Line Lender and an L/C Issuer, and the other lenders party thereto as amended and modified from time to time, that certain Term Loan Agreement, dated as of August 16, 2019, by and among the Partnership, as borrower,
Toronto Dominion (Texas) LLC, as administrative agent and the lenders party thereto as amended and modified from time to time and any other document governing permitted indebtedness of the Partnership, no subsidiary of the Partnership is currently
prohibited, directly or indirectly, under any agreement or other instrument, subject to the Eureka Credit Agreement and the Eureka Joint Venture LLC Agreement, to which it is a party or is subject, from paying any dividends to the Partnership, from
making any other distribution on such subsidiary’s capital stock or similar ownership interest, from repaying to the Partnership any loans or advances to such subsidiary from the Partnership or from transferring any of such subsidiary’s
properties or assets to the Partnership or any other subsidiary of the Partnership, except for any such restrictions (a) as described in each of the Time of Sale Information and the Offering Memorandum, or (b) that will be permitted by the
Indenture. 
 (oo)    No Broker’s Fees. None of the Partnership Entities is a party to any contract,
agreement or understanding with any person (other than this Agreement) that would give rise to a valid claim against any of them or any Initial Purchaser for a brokerage commission, finder’s fee or like payment in connection with the offering
and sale of the Securities. 
 (pp)    Rule 144A Eligibility. On the Closing Date, the Securities will not
be of the same class as securities listed on a national securities exchange registered under Section 6 of the Exchange Act or quoted in an automated inter-dealer quotation system; and each of the Preliminary Offering Memorandum and the Offering
Memorandum, as of its respective date, contains or will contain all the information that, if requested by a prospective purchaser of the Securities, would be required to be provided to such prospective purchaser pursuant to Rule 144A(d)(4) under the
Securities Act. 
 (qq)     No Integration. Neither the Partnership nor any of its affiliates (as defined
in Rule 501(b) of Regulation D) has, directly or through any agent, sold, offered for sale, solicited offers to buy or otherwise negotiated in respect of, any security (as defined in the Securities Act), that is or will be integrated with the sale
of the Securities in a manner that would require registration of the Securities under the Securities Act. 

  
 18 

 (rr)    No General Solicitation or Directed Selling Efforts. None
of the Partnership or any of its affiliates or any other person acting on its or their behalf (other than the Initial Purchasers, as to which no representation is made) has (i) solicited offers for, or offered or sold, the Securities by means
of any form of general solicitation or general advertising within the meaning of Rule 502(c) of Regulation D or in any manner involving a public offering within the meaning of Section 4(a)(2) of the Securities Act or (ii) engaged in any
directed selling efforts within the meaning of Regulation S under the Securities Act (“Regulation S”), and all such persons have complied with the offering restrictions requirement of Regulation S. 

(ss)    Securities Law Exemptions. Assuming the accuracy of the representations and warranties of the Initial
Purchasers contained in Section 2(b) hereof (including Annex C hereto) and their compliance with their agreements set forth therein, it is not necessary, in connection with the issuance and sale of the Securities to the Initial Purchasers and
the offer, resale and delivery of the Securities by the Initial Purchasers in the manner contemplated by this Agreement, the Time of Sale Information and the Offering Memorandum, to register the Securities under the Securities Act or to qualify the
Indenture under the Trust Indenture Act of 1939, as amended. 
 (tt)    No Stabilization. The Partnership has not
taken, directly or indirectly, any action designed to or that would constitute or that might reasonably be expected to cause or result in, under the Exchange Act or otherwise, stabilization or manipulation of the price of any security of the
Partnership to facilitate the sale or resale of the Securities. 
 (uu)    Margin Rules. Neither the issuance,
sale and delivery of the Securities nor the application of the proceeds thereof by the Partnership as described in each of the Time of Sale Information and the Offering Memorandum will violate Regulation T, U or X of the Board of Governors of the
Federal Reserve System or any other regulation of such Board of Governors. 
 (vv)    Forward-Looking Statements.
No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act) included or incorporated by reference in any of the Time of Sale Information or the Offering Memorandum has been
made or reaffirmed without a reasonable basis or has been disclosed other than in good faith. 
 (ww)    Statistical
and Market Data. All statistical and market-related data included in or incorporated by reference in the Time of Sale Information and the Offering Memorandum are based on or derived from sources that the Partnership believes to be reliable and
accurate in all material respects, and the Partnership has obtained the written consent to the use of such data from such sources to the extent required. 

  
 19 

 (xx)    Cybersecurity; Data Protection. The Partnership
Entities’ information technology assets and equipment, computers, systems, networks, hardware, software, websites, applications, and databases (collectively, “IT Systems”) are adequate for, and operate and perform in all
material respects as required in connection with the operation of the business of the Partnership Entities as currently conducted, to the Partnership’s knowledge, free and clear of all material bugs, errors, defects, Trojan horses, time bombs,
malware and other corruptants. The Partnership Entities have implemented and maintained commercially reasonable controls, policies, procedures, and safeguards designed to maintain and protect their material confidential information and the
integrity, continuous operation, redundancy and security of all IT Systems and data (including all personal, personally identifiable, sensitive, confidential or regulated data (“Personal Data”)) used in connection with their
businesses, and to the knowledge of the Partnership, there have been no breaches, violations, outages or unauthorized uses of or accesses to same, nor any incidents under internal review or investigations relating to the same, except, in each case,
for those that have been remedied, or are reasonably expected to be remediated, without material cost or liability or the duty to notify any other person. The Partnership Entities are presently in material compliance with all applicable laws or
statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Personal Data and to
the protection of such IT Systems and Personal Data from unauthorized use, access, misappropriation or modification. 

(yy)    Sarbanes-Oxley Act. Equitrans and its officers and directors, in their capacities as such, are as of the
date hereof, and on the Closing Date will be, in compliance in all respects with the applicable provisions of the Sarbanes-Oxley Act of 2002. 

(zz)    Operations of Equitrans. Equitrans has no material operations other than those conducted by the Partnership
and its subsidiaries. 
 4. Further Agreements of the Partnership. The Partnership covenants and agrees with each Initial Purchaser
that: 
 (a)    Delivery of Copies. The Partnership will deliver, without charge, to the Initial Purchasers as
many copies of the Preliminary Offering Memorandum, any other Time of Sale Information, any Issuer Written Communication and the Offering Memorandum (including all amendments and supplements thereto) as the Representative may reasonably request.

 (b)    Offering Memorandum, Amendments or Supplements. Before finalizing the Offering Memorandum or making or
distributing any amendment or supplement to any of the Time of Sale Information or the Offering Memorandum or filing with the Commission any document that will be incorporated by reference therein, the Partnership will furnish to the Representative
and counsel for the Initial Purchasers a copy of the proposed Offering Memorandum or such amendment or supplement or document to be incorporated by reference therein for review, and will not distribute any such proposed Offering Memorandum,
amendment or supplement or file any such document with the Commission to which the Representative reasonably objects. 

  
 20 

 (c)    Additional Written Communications. Before making,
preparing, using, authorizing, approving or referring to any Issuer Written Communication, the Partnership will furnish to the Representative and counsel for the Initial Purchasers a copy of such written communication for review and will not make,
prepare, use, authorize, approve or refer to any such written communication to which the Representative reasonably objects. 

(d)    Notice to the Representative. The Partnership will advise the Representative promptly, and confirm such
advice in writing, (i) of the issuance by any governmental or regulatory authority of any order preventing or suspending the use of any of the Time of Sale Information, any Issuer Written Communication or the Offering Memorandum or the
initiation or threatening of any proceeding for that purpose; (ii) of the occurrence of any event at any time prior to the completion of the initial offering of the Securities as a result of which any of the Time of Sale Information, any Issuer
Written Communication or the Offering Memorandum as then amended or supplemented would include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the
circumstances existing when such Time of Sale Information, Issuer Written Communication or the Offering Memorandum is delivered to a purchaser, not misleading; and (iii) of the receipt by the Partnership of any notice with respect to any
suspension of the qualification of the Securities for offer and sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and the Partnership will use its reasonable best efforts to prevent the issuance of any
such order preventing or suspending the use of any of the Time of Sale Information, any Issuer Written Communication or the Offering Memorandum or suspending any such qualification of the Securities and, if any such order is issued, will obtain as
soon as possible the withdrawal thereof. 
 (e)    Time of Sale Information. If at any time prior to the Closing
Date (i) any event shall occur or condition shall exist as a result of which any of the Time of Sale Information as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary
in order to make the statements therein, in the light of the circumstances under which they were made, not misleading or (ii) it is necessary to amend or supplement the Time of Sale Information to comply with law, the Partnership will
immediately notify the Initial Purchasers thereof and forthwith prepare and, subject to paragraph (b) above, furnish to the Initial Purchasers such amendments or supplements to the Time of Sale Information (or any document to be filed with the
Commission and incorporated by reference therein) as may be necessary so that the statements in any of the Time of Sale Information as so amended or supplemented (including such documents to be incorporated by reference therein) will not, in the
light of the circumstances under which they were made, be misleading or so that any of the Time of Sale Information will comply with law. 

  
 21 

 (f)    Ongoing Compliance. If at any time prior to the completion
of the initial offering of the Securities (i) any event shall occur or condition shall exist as a result of which the Offering Memorandum as then amended or supplemented would include any untrue statement of a material fact or omit to state any
material fact necessary in order to make the statements therein, in the light of the circumstances existing when the Offering Memorandum is delivered to a purchaser, not misleading or (ii) it is necessary to amend or supplement the Offering
Memorandum to comply with law, the Partnership will immediately notify the Initial Purchasers thereof and forthwith prepare and, subject to paragraph (b) above, furnish to the Initial Purchasers such amendments or supplements to the Offering
Memorandum (or any document to be filed with the Commission and incorporated by reference therein) as may be necessary so that the statements in the Offering Memorandum as so amended or supplemented (including such document to be incorporated by
reference therein) will not, in the light of the circumstances existing when the Offering Memorandum is delivered to a purchaser, be misleading or so that the Offering Memorandum will comply with law. 

(g)    Blue Sky Compliance. The Partnership will qualify the Securities for offer and sale under the securities or
Blue Sky laws of such jurisdictions as the Representative shall reasonably request and will continue such qualifications in effect so long as required for the offering and resale of the Securities; provided that the Partnership shall not be
required to (i) qualify as a foreign corporation or other entity or as a dealer in securities in any such jurisdiction where it would not otherwise be required to so qualify, (ii) file any general consent to service of process in any such
jurisdiction or (iii) subject itself to taxation in any such jurisdiction if it is not otherwise so subject. 

(h)    Clear Market. During the period from the date hereof through and including the date that is 30 days after
the date hereof, the Partnership will not, without the prior written consent of the Representative, offer, sell, contract to sell or otherwise dispose of any debt securities issued or guaranteed by the Partnership and having a tenor of more than one
year. 
 (i)    Use of Proceeds. The Partnership will apply the net proceeds from the sale of the Securities as
described in each of the Time of Sale Information and the Offering Memorandum under the heading “Use of proceeds.” 

(j)    Supplying Information. While the Securities remain outstanding and are “restricted securities”
within the meaning of Rule 144(a)(3) under the Securities Act, the Partnership will, during any period in which the Partnership is not subject to and in compliance with Section 13 or 15(d) of the Exchange Act, furnish to holders of the
Securities and prospective purchasers of the Securities designated by such holders, upon the request of such holders or such prospective purchasers, the information required to be delivered pursuant to Rule 144A(d)(4) under the Securities Act;
provided, however, that the Partnership will not otherwise be required to deliver any additional information other than information required to be delivered under the Indenture governing the Securities. 

  
 22 

 (k)    DTC. The Partnership will assist the Initial Purchasers in
arranging for the Securities to be eligible for clearance and settlement through DTC. 
 (l)    No Resales by the
Partnership. The Partnership will not, and will not permit any of its affiliates (as defined in Rule 144 under the Securities Act) to, resell any of the Securities that have been acquired by any of them, except for Securities purchased by
the Partnership or any of its affiliates and resold in a transaction registered under the Securities Act. 

(m)    No Integration. Neither the Partnership nor any of its affiliates (as defined in Rule 501(b) of Regulation
D) will, directly or through any agent, sell, offer for sale, solicit offers to buy or otherwise negotiate in respect of, any security (as defined in the Securities Act), that is or will be integrated with the sale of the Securities in a manner that
would require registration of the Securities under the Securities Act. 
 (n)    No General Solicitation or Directed
Selling Efforts. None of the Partnership or any of its affiliates or any other person acting on its or their behalf (other than the Initial Purchasers, as to which no covenant is given) will (i) solicit offers for, or offer or sell, the
Securities by means of any form of general solicitation or general advertising within the meaning of Rule 502(c) of Regulation D or in any manner involving a public offering within the meaning of Section 4(a)(2) of the Securities Act or
(ii) engage in any directed selling efforts within the meaning of Regulation S, and all such persons will comply with the offering restrictions requirement of Regulation S. 

(o)    No Stabilization. The Partnership will not take, directly or indirectly, any action designed to or that
could reasonably be expected to cause or result in any stabilization or manipulation of the price of the Securities. 
 5. Certain
Agreements of the Initial Purchasers. Each Initial Purchaser hereby represents and agrees that it has not and will not use, authorize use of, refer to, or participate in the planning for use of, any written communication that constitutes an
offer to sell or the solicitation of an offer to buy the Securities other than (i) the Preliminary Offering Memorandum and the Offering Memorandum, (ii) any written communication that contains either (a) no
“issuer information” (as defined in Rule 433(h)(2) under the Securities Act) or (b) “issuer information” that was included (including through incorporation by reference) in the Time of Sale Information or the Offering Memorandum,
(iii) any written communication listed on Annex A or prepared pursuant to Section 4(c) (including any electronic road show) above, (iv) any written communication prepared by such Initial Purchaser and approved by
the Partnership and the Representative in advance in writing or (v) any written communication relating to or that contains the terms of the Securities and/or other information that was included (including through incorporation by
reference) in the Time of Sale Information or the Offering Memorandum. 

  
 23 

 6. Conditions of Initial Purchasers’ Obligations. The obligation of each Initial
Purchaser to purchase Securities on the Closing Date as provided herein is subject to the performance by the Partnership of its covenants and other obligations hereunder and to the following additional conditions: 

(a)    Representations and Warranties. The representations and warranties of the Partnership and Equitrans contained
herein shall be true and correct on the date hereof and on and as of the Closing Date; and the statements of the Partnership and the officers of the General Partner made in any certificates delivered pursuant to this Agreement shall be true and
correct on and as of the Closing Date. 
 (b)    No Downgrade. Subsequent to the earlier of (A) the Time of
Sale and (B) the execution and delivery of this Agreement, (i) no downgrading shall have occurred in the rating accorded the Securities or any other debt securities or preferred stock issued or guaranteed by any of the Partnership Entities
or Equitrans by any “nationally recognized statistical rating organization,” as such term is defined under Section 3(a)(62) under the Exchange Act, and (ii) no such organization shall have publicly announced that it has under
surveillance or review, or has changed its outlook with respect to, its rating of the Securities or of any other debt securities or preferred stock issued or guaranteed by the Partnership Entities or Equitrans (other than an announcement with
positive implications of a possible upgrading). 
 (c)    No Material Adverse Change. No event or condition of a
type described in Section 3(e) hereof shall have occurred or shall exist, which event or condition is not described in each of the Time of Sale Information (excluding any amendment or supplement thereto) and the Offering Memorandum (excluding
any amendment or supplement thereto) the effect of which in the judgment of the Representative makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Securities on the terms and in the manner contemplated by this
Agreement, the Time of Sale Information and the Offering Memorandum. 
 (d)    Officer’s Certificate. The
Representative shall have received on and as of the Closing Date a certificate of an executive officer of Equitrans and the General Partner who has specific knowledge of Equitrans’ and the Partnership’s respective financial matters and is
satisfactory to the Representative (i) confirming that such officer of the General Partner has carefully reviewed the Time of Sale Information and the Offering Memorandum and, to the knowledge of such officer, the representations set forth in
Sections 3(a) and 3(b) hereof are true and correct, (ii) confirming that the other representations and warranties of Equitrans and the Partnership in this Agreement are true and correct and that the Partnership and Equitrans, respectively, have
complied with all agreements and satisfied all conditions on their part to be performed or satisfied hereunder at or prior to the Closing Date and (iii) to the effect set forth in paragraphs (b), with respect to the Partnership and (c), with
respect to the Partnership and Equitrans (provided that no representation with respect to the judgment of the Representative need be made) above. 

(e)    Comfort Letter. On the date of this Agreement and on the Closing Date, Ernst & Young LLP shall
have furnished to the Representative, at the request of Equitrans and the Partnership, one or more letters, dated the respective dates of 

  
 24 

 
delivery thereof and addressed to the Initial Purchasers, in form and substance reasonably satisfactory to the Representative, containing statements and information of the type customarily
included in accountants’ “comfort letters” to underwriters with respect to the financial statements and certain financial information of Equitrans, the Partnership and their respective subsidiaries contained or incorporated by
reference in each of the Time of Sale Information and the Offering Memorandum; provided that the letter or letters delivered on the Closing Date shall use a “cut-off” date no more than three
business days prior to the Closing Date. 
 (f)    Opinion and 10b-5
Statement of Counsel for the Partnership. Latham & Watkins LLP, counsel for the Partnership, shall have furnished to the Representative, at the request of the Partnership, their written opinion and
10b-5 statement, dated the Closing Date and addressed to the Initial Purchasers, in form and substance reasonably satisfactory to the Representative. 

(g)    Opinion and 10b-5 Statement of Counsel for the Initial Purchasers.
The Representative shall have received on and as of the Closing Date an opinion and 10b-5 statement, addressed to the Initial Purchasers, of Simpson Thacher & Bartlett LLP, counsel for the Initial
Purchasers, with respect to such matters as the Representative may reasonably request, and such counsel shall have received such documents and information as they may reasonably request to enable them to pass upon such matters. 

(h)    Opinion of the General Counsel. The Representative shall have received on and as of the Closing Date an
opinion, addressed to the Initial Purchasers, of Stephen M. Moore, general counsel of Equitrans, in form and substance reasonably satisfactory to the Representative. 

(i)    No Legal Impediment to Issuance. No action shall have been taken and no statute, rule, regulation or
order shall have been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date, prevent the issuance or sale of the Securities; and no injunction or order of any federal,
state or foreign court shall have been issued that would, as of the Closing Date, prevent the issuance or sale of the Securities. 

(j)    Good Standing. The Representative shall have received on and as of the Closing Date satisfactory evidence of
the good standing of the Partnership Entities in their respective jurisdictions of organization and their good standing in such other jurisdictions as the Representative may reasonably request, in each case in writing or any standard form of
telecommunication from the appropriate governmental authorities of such jurisdictions. 
 (k)    DTC. The
Securities shall be eligible for clearance and settlement through DTC. 
 (l)    Indenture and Securities. The
Indenture shall have been duly executed and delivered by a duly authorized officer of the General Partner and the Trustee, and the Securities shall have been duly executed and delivered by a duly authorized officer of the General Partner and duly
authenticated by the Trustee. 

  
 25 

 (m)    Additional Documents. On or prior to the Closing Date, the
Partnership shall have furnished to the Representative such further certificates and documents as the Representative may reasonably request. 

All opinions, letters, certificates and evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the
provisions hereof only if they are in form and substance reasonably satisfactory to counsel for the Initial Purchasers. 
 7.
Indemnification and Contribution.  
 (a)    Indemnification of the Initial Purchasers. The
Partnership agrees to indemnify and hold harmless each Initial Purchaser, its affiliates, directors and officers and each person, if any, who controls such Initial Purchaser within the meaning of Section 15 of the Securities Act or
Section 20 of the Exchange Act, from and against any and all losses, claims, damages and liabilities (including, without limitation, legal fees and other expenses reasonably incurred in connection with any suit, action or proceeding or any
claim asserted, as such fees and expenses are reasonably incurred), joint or several, that arise out of, or are based upon, any untrue statement or alleged untrue statement of a material fact contained in the Preliminary Offering Memorandum, any of
the other Time of Sale Information, any Issuer Written Communication or the Offering Memorandum (or any amendment or supplement thereto) or any omission or alleged omission to state therein a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading, in each case except insofar as such losses, claims, damages or liabilities arise out of, or are based upon, any untrue statement or omission or alleged untrue
statement or omission made in reliance upon and in conformity with any information relating to any Initial Purchaser furnished to the Partnership in writing by such Initial Purchaser through the Representative expressly for use therein. 

(b)    Indemnification of the Partnership. Each Initial Purchaser agrees, severally and not jointly, to
indemnify and hold harmless the Partnership, each of the General Partner’s directors and officers and each person, if any, who controls the Partnership within the meaning of Section 15 of the Securities Act or Section 20 of the
Exchange Act to the same extent as the indemnity set forth in paragraph (a) above, but only with respect to any losses, claims, damages or liabilities that arise out of, or are based upon, any untrue statement or omission or alleged untrue
statement or omission made in reliance upon and in conformity with any information relating to such Initial Purchaser furnished to the Partnership in writing by such Initial Purchaser through the Representative expressly for use in the Preliminary
Offering Memorandum, any of the other Time of Sale Information, any Issuer Written Communication or the Offering Memorandum (or any amendment or supplement thereto), it being understood and agreed that the only such information consists of the
following paragraphs in the Preliminary Offering Memorandum and the Offering Memorandum: (i) the third paragraph, (ii) the fourth sentence of the seventh paragraph and (iii) the eighth paragraph, in each case, under the caption
“Plan of Distribution.” 

  
 26 

 (c)    Notice and Procedures. If any suit,
action, proceeding (including any governmental or regulatory investigation), claim or demand shall be brought or asserted against any person in respect of which indemnification may be sought pursuant to either paragraph (a) or (b) above, such person
(the “Indemnified Person”) shall promptly notify the person against whom such indemnification may be sought (the “Indemnifying Person”) in writing; provided that the failure to notify the Indemnifying Person
shall not relieve it from any liability that it may have under paragraph (a) or (b) above except to the extent that it has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and provided,
further, that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have to an Indemnified Person otherwise than under paragraph (a) or (b) above. If any such proceeding shall be brought or asserted
against an Indemnified Person and it shall have notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably satisfactory to the Indemnified Person (who shall not, without the consent of the Indemnified Person,
be counsel to the Indemnifying Person) to represent the Indemnified Person and any others entitled to indemnification pursuant to this Section 7 that the Indemnifying Person may designate in such proceeding and shall pay the fees and expenses of
such proceeding and shall pay the fees and expenses of such counsel related to such proceeding, as incurred. In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such counsel
shall be at the expense of such Indemnified Person unless (i) the Indemnifying Person and the Indemnified Person shall have mutually agreed to the contrary; (ii) the Indemnifying Person has failed within a reasonable time to retain counsel
reasonably satisfactory to the Indemnified Person; (iii) the Indemnified Person shall have reasonably concluded that there may be legal defenses available to it that are different from or in addition to those available to the Indemnifying
Person; or (iv) the named parties in any such proceeding (including any impleaded parties) include both the Indemnifying Person and the Indemnified Person and the Indemnified Person shall have reasonably concluded that the representation of both
parties by the same counsel would be inappropriate due to actual or potential differing interests between them. It is understood and agreed that the Indemnifying Person shall not, in connection with any proceeding or related proceeding in the same
jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to any local counsel) for all Indemnified Persons, and that all such fees and expenses shall be paid or reimbursed as they are incurred. Any such separate
firm for any Initial Purchaser, its affiliates, directors and officers and any control persons of such Initial Purchaser shall be designated in writing by Barclays Capital Inc. and any such separate firm for the Partnership, its directors and
officers and any control persons of the Partnership shall be designated in writing by the Partnership. The Indemnifying Person shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such
consent or if there be a final judgment for the plaintiff, the Indemnifying Person agrees to indemnify each Indemnified Person from and against any loss or liability by reason of such settlement or judgment. Notwithstanding the foregoing sentence,
if at any time an Indemnified Person shall have requested that an Indemnifying Person reimburse the Indemnified Person for fees and 

  
 27 

 
expenses of counsel as contemplated by this paragraph, the Indemnifying Person shall be liable for any settlement of any proceeding effected without its written consent if (i) such
settlement is entered into more than 45 days after receipt by the Indemnifying Person of such request, (ii) the Indemnifying Person shall have received notice of the terms of such settlement at least 30 days prior to such settlement being
entered into and (iii) the Indemnifying Person shall not have reimbursed the Indemnified Person in accordance with such request prior to the date of such settlement. No Indemnifying Person shall, without the written consent of the Indemnified
Person, effect any settlement of any pending or threatened proceeding in respect of which any Indemnified Person is or could have been a party and indemnification could have been sought hereunder by such Indemnified Person, unless such settlement
(x) includes an unconditional release of such Indemnified Person, in form and substance reasonably satisfactory to such Indemnified Person, from all liability on claims that are the subject matter of such proceeding and (y) does not
include any statement as to or any admission of fault, culpability or a failure to act by or on behalf of any Indemnified Person. 

(d)    Contribution. If the indemnification provided for in paragraph (a) or (b) above is unavailable to an
Indemnified Person or insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu of indemnifying such Indemnified Person thereunder, shall contribute to the
amount paid or payable by such Indemnified Person as a result of such losses, claims, damages or liabilities (i) in such proportion as is appropriate to reflect the relative benefits received by the Partnership on the one hand and the Initial
Purchasers on the other from the offering of the Securities or (ii) if the allocation provided by clause (i) is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in
clause (i) but also the relative fault of the Partnership on the one hand and the Initial Purchasers on the other in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other
relevant equitable considerations. The relative benefits received by the Partnership on the one hand and the Initial Purchasers on the other shall be deemed to be in the same respective proportions as the net proceeds (before deducting expenses)
received by the Partnership from the sale of the Securities and the total discounts and commissions received by the Initial Purchasers in connection therewith, as provided in this Agreement, bear to the aggregate offering price of the Securities.
The relative fault of the Partnership on the one hand and the Initial Purchasers on the other shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged
omission to state a material fact relates to information supplied by the Partnership or by the Initial Purchasers and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or
omission. 
 (e)    Limitation on Liability. The Partnership and the Initial Purchasers agree that it would not
be just and equitable if contribution pursuant to this Section 7 were determined by pro rata allocation (even if the Initial Purchasers were treated as one entity for such purpose) or by any other method of allocation that does
not take account of the equitable considerations referred to in paragraph (d) above. The amount paid or 

  
 28 

 
payable by an Indemnified Person as a result of the losses, claims, damages and liabilities referred to in paragraph (d) above shall be deemed to include, subject to the limitations set
forth above, any legal or other expenses reasonably incurred by such Indemnified Person in connection with any such action or claim. Notwithstanding the provisions of this Section 7, in no event shall an Initial Purchaser be required to
contribute any amount in excess of the amount by which the total discounts and commissions received by such Initial Purchaser with respect to the offering of the Securities exceeds the amount of any damages that such Initial Purchaser has otherwise
been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent misrepresentation. The Initial Purchasers’ obligations to contribute pursuant to this Section 7 are several in proportion to their respective purchase obligations hereunder
and not joint. 
 (f)    Non-Exclusive Remedies. The remedies provided
for in this Section 7 are not exclusive and shall not limit any rights or remedies that may otherwise be available to any Indemnified Person at law or in equity. 

8. Effectiveness of Agreement. This Agreement shall become effective as of the date first written above. 

9. Termination. This Agreement may be terminated in the absolute discretion of the Representative, by notice to the Partnership, if
after the execution and delivery of this Agreement and on or prior to the Closing Date (i) trading generally shall have been suspended or materially limited on the New York Stock Exchange or the over-the-counter market; (ii) trading of any securities issued or guaranteed by Equitrans or any of the Partnership Entities shall have been suspended on any exchange or in any over-the-counter market; (iii) a general moratorium on commercial banking activities shall have been declared by federal or New York State authorities; or (iv) there
shall have occurred any outbreak or escalation of hostilities or any change in financial markets or any calamity or crisis, either within or outside the United States, that, in the judgment of the Representative, is material and adverse and makes it
impracticable or inadvisable to proceed with the offering, sale or delivery of the Securities on the terms and in the manner contemplated by this Agreement, the Time of Sale Information and the Offering Memorandum. 

10. Defaulting Initial Purchaser. 

(a)    If, on the Closing Date, any Initial Purchaser defaults on its obligation to purchase the Securities that it has
agreed to purchase hereunder, the non-defaulting Initial Purchasers may in their discretion arrange for the purchase of such Securities by other persons satisfactory to the Partnership on the terms contained
in this Agreement. If, within 36 hours after any such default by any Initial Purchaser, the non-defaulting Initial Purchasers do not arrange for the purchase of such Securities, then the Partnership shall be
entitled to a further period of 36 hours within which to procure other persons satisfactory to the non-defaulting Initial Purchasers to purchase such Securities

  
 29 

 
on such terms. If other persons become obligated or agree to purchase the Securities of a defaulting Initial Purchaser, either the non-defaulting Initial
Purchasers or the Partnership may postpone the Closing Date for up to five full business days in order to effect any changes that in the opinion of counsel for the Partnership or counsel for the Initial Purchasers may be necessary in the Time of
Sale Information, the Offering Memorandum or in any other document or arrangement, and the Partnership agrees to promptly prepare any amendment or supplement to the Time of Sale Information or the Offering Memorandum that effects any such changes.
As used in this Agreement, the term “Initial Purchaser” includes, for all purposes of this Agreement unless the context otherwise requires, any person not listed in Schedule 1 hereto that, pursuant to this Section 10, purchases
Securities that a defaulting Initial Purchaser agreed but failed to purchase. 
 (b)    If, after giving effect to any
arrangements for the purchase of the Securities of a defaulting Initial Purchaser or Initial Purchasers by the non-defaulting Initial Purchasers and the Partnership as provided in paragraph (a) above, the
aggregate principal amount of such Securities that remains unpurchased does not exceed one-eleventh of the aggregate principal amount of all the Securities, then the Partnership shall have the right to require
each non-defaulting Initial Purchaser to purchase the principal amount of Securities that such Initial Purchaser agreed to purchase hereunder plus such Initial Purchaser’s pro rata share
(based on the principal amount of Securities that such Initial Purchaser agreed to purchase hereunder) of the Securities of such defaulting Initial Purchaser or Initial Purchasers for which such arrangements have not been made. 

(c)    If, after giving effect to any arrangements for the purchase of the Securities of a defaulting Initial Purchaser or
Initial Purchasers by the non-defaulting Initial Purchasers and the Partnership as provided in paragraph (a) above, the aggregate principal amount of such Securities that remains unpurchased exceeds one-eleventh of the aggregate principal amount of all the Securities, or if the Partnership shall not exercise the right described in paragraph (b) above, then this Agreement shall terminate without liability
on the part of the non-defaulting Initial Purchasers. Any termination of this Agreement pursuant to this Section 10 shall be without liability on the part of the Partnership, except that the Partnership
will continue to be liable for the payment of expenses as set forth in Section 11 hereof and except that the provisions of Section 7 hereof shall not terminate and shall remain in effect. 

(d)    Nothing contained herein shall relieve a defaulting Initial Purchaser of any liability it may have to the
Partnership or any non-defaulting Initial Purchaser for damages caused by its default. 
 11.
Payment of Expenses. 
 (a) Whether or not the transactions contemplated by this Agreement are consummated or this Agreement is
terminated, the Partnership agrees to pay or cause to be paid all costs and expenses incident to the performance of its obligations hereunder, including without limitation, (i) the costs incident to the authorization,

  
 30 

 
issuance, sale, preparation and delivery of the Securities and any taxes payable in that connection; (ii) the costs incident to the preparation and printing of the Preliminary Offering
Memorandum, any other Time of Sale Information, any Issuer Written Communication and the Offering Memorandum (including any amendment or supplement thereto) and the distribution thereof; (iii) the costs of reproducing and distributing each of
the Transaction Documents; (iv) the fees and expenses of the Partnership’s counsel and independent accountants; (v) the fees and expenses incurred in connection with the registration or qualification and determination of eligibility
for investment of the Securities under the laws of such jurisdictions as the Representative may designate and the preparation, printing and distribution of a Blue Sky Memorandum (including reasonable and documented related fees and expenses of
counsel for the Initial Purchasers not to exceed $20,000); (vi) any fees charged by rating agencies for rating the Securities; (vii) the fees and expenses of the Trustee and any paying agent (including related fees and expenses of any
counsel to such parties); (viii) all expenses and application fees incurred in connection with the approval of the Securities for book-entry transfer by DTC; and (ix) all expenses incurred by the Partnership in connection with any “road
show” presentation to potential investors. Except as provided in Section 7 and this Section 11(a) and in Section 11(b), the Initial Purchasers shall pay their own expenses, including the fees and disbursements of their
counsel, transfer taxes on any resale of the Securities by any Initial Purchaser, any advertising expenses connected with any offers they may make and other expenses incurred by the Initial Purchasers on their own behalf in connection with
presentations to prospective purchasers of the Securities. 
 (b)    If (i) this Agreement is terminated pursuant
to Section 9(i) or Section 9(ii) hereof, (ii) the Partnership for any reason fails to tender the Securities for delivery to the Initial Purchasers (other than by reason of a default by any of the Initial Purchasers except pursuant to
Section 10(c)) or (iii) any condition to the obligations of the Initial Purchasers contained herein for the Closing Date is not met or waived, the Partnership agrees to reimburse the Initial Purchasers for all out-of-pocket costs and expenses (including the reasonable fees and expenses of their counsel) incurred by the Initial Purchasers in connection with this Agreement and the
offering contemplated hereby. 
 12. Persons Entitled to Benefit of Agreement. This Agreement shall inure to the benefit of and be
binding upon the parties hereto and their respective successors and the officers and directors and any controlling persons referred to herein, and the affiliates of each Initial Purchaser referred to in Section 7 hereof. Nothing in this
Agreement is intended or shall be construed to give any other person any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein. No purchaser of Securities from any Initial Purchaser shall
be deemed to be a successor merely by reason of such purchase. 
 13. Survival. The respective indemnities, rights of contribution,
representations, warranties and agreements of the Partnership and the Initial Purchasers contained in this Agreement or made by or on behalf of the Partnership or the Initial Purchasers pursuant to this Agreement or any certificate delivered
pursuant hereto shall survive the delivery of and payment for the Securities and shall remain in full force and effect, regardless of any termination of this Agreement or any investigation made by or on behalf of the Partnership or the Initial
Purchasers. 

  
 31 

 14. Certain Defined Terms. For purposes of this Agreement, (a) except where
otherwise expressly provided, the term “affiliate” has the meaning set forth in Rule 405 under the Securities Act; (b) the term “business day” means any day other than a day on which banks are permitted or
required to be closed in New York City; (c) the term “subsidiary” has the meaning set forth in Rule 405 under the Securities Act; (d) the term “Exchange Act” collectively means the Securities Exchange Act
of 1934, as amended, and the rules and regulations of the Commission thereunder; and (e) the term “written communication” has the meaning set forth in Rule 405 under the Securities Act. 

15. Compliance with USA Patriot Act. In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)), the Initial Purchasers are required to obtain, verify and record information that identifies their respective clients, including the Partnership, which information
may include the name and address of their respective clients, as well as other information that will allow the Initial Purchasers to properly identify their respective clients. 

16. Miscellaneous.  

(a)    Authority of the Representative. Any action by the Initial Purchasers hereunder may be taken by
Barclays Capital Inc. on behalf of the Initial Purchasers, and any such action taken by Barclays Capital Inc. shall be binding upon the Initial Purchasers. 

(b)    Notices. All notices and other communications hereunder shall be in writing and shall be deemed to have been
duly given if mailed or transmitted and confirmed by any standard form of telecommunication. Notices to the Initial Purchasers shall be given to the Representative c/o Barclays Capital Inc., 745 7th Avenue, New York, New York 10019; Attention:
Syndicate Registration. Notices to the Partnership shall be given to them at EQM Midstream Partners, LP; c/o EQGP Services, LLC; 2200 Energy Drive; Canonsburg, Pennsylvania 15317; Attention: General Counsel. 

(c)    Governing Law. This Agreement and any claim, controversy or dispute arising under or related to this
Agreement shall be governed by and construed in accordance with the laws of the State of New York. 

(d)    Submission to Jurisdiction. The Partnership hereby submits to the exclusive jurisdiction of the U.S. federal
and New York state courts in the Borough of Manhattan in The City of New York in any suit or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. The Partnership waives any objection which it may now or
hereafter have to the laying of venue of any such suit or proceeding in such courts. The Partnership agrees that final judgment in any such suit, action or proceeding brought in such court shall be conclusive and binding upon the Partnership and may
be enforced in any court to the jurisdiction of which Company is subject by a suit upon such judgment. 

  
 32 

 (e)    Waiver of Jury Trial. Each of the parties hereto hereby
waives any right to trial by jury in any suit or proceeding arising out of or relating to this Agreement. 

(f)    Recognition of the U.S. Special Resolution Regimes. 

(i)    In the event that any Initial Purchaser that is a Covered Entity becomes subject to a proceeding
under a U.S. Special Resolution Regime, the transfer from such Initial Purchaser of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S.
Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States. 

(ii)    In the event that any Initial Purchaser that is a Covered Entity or a BHC Act Affiliate of such
Initial Purchaser becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Initial Purchaser are permitted to be exercised to no greater extent than such Default
Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. 

As used in this Section 16(f): 

“BHC Act Affiliate” has the meaning assigned to the term “affiliate” in, and shall be interpreted in accordance with, 12
U.S.C. § 1841(k). 
 “Covered Entity” means any of the following: 

(i) a “covered entity” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b); 

(ii) a “covered bank” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b); or 

(iii) a “covered FSI” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b). 

“Default Right” has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81,
47.2 or 382.1, as applicable. 
 “U.S. Special Resolution Regime” means each of (i) the Federal Deposit Insurance Act and the
regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder. 

(g)    Counterparts. This Agreement may be signed in counterparts (which may include counterparts delivered by any
standard form of telecommunication), each of 
  

  
 33 

 
which shall be an original and all of which together shall constitute one and the same instrument. The words “execution,” “signed,” “signature,”
“delivery,” and words of like import in or relating to this Agreement or any document to be signed in connection with this Agreement shall be deemed to include electronic signatures, deliveries or the keeping of records in electronic form,
each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be, and the parties hereto consent to conduct
the transactions contemplated hereunder by electronic means. 
 (h)    Amendments or Waivers. No amendment or
waiver of any provision of this Agreement, nor any consent or approval to any departure therefrom, shall in any event be effective unless the same shall be in writing and signed by the parties hereto. 

(i)    Headings. The headings herein are included for convenience of reference only and are not intended to be part
of, or to affect the meaning or interpretation of, this Agreement. 
 (j)    Integration. This Agreement
supersedes all prior agreements and understandings (whether written or oral) between the Partnership and the Initial Purchasers, or any of them, with respect to the subject matter hereof. 

[Remainder of page intentionally left blank] 

  
 34 

 If the foregoing is in accordance with your understanding, please indicate your acceptance
of this Agreement by signing in the space provided below. 
  

			
	 Very truly yours,
  

	EQM MIDSTREAM PARTNERS, LP
		
	By:	 	EQGP Services, LLC,
	its general partner
		
	By:	 	 /s/ Kirk R. Oliver

	Name:	 	Kirk R. Oliver
	Title:	 	Senior Vice President and Chief Financial Officer
	
	Solely with respect to Sections 3(c), 3(d)(ii), 3(i), 3(v)(ii), 3(gg)(ii), 3(hh), 3(ii), 3(yy), 3(zz), 6(a), 6(b), 6(d) and 6(e):
	
	EQUITRANS MIDSTREAM CORPORATION
		
	By:	 	 /s/ Kirk R. Oliver

	Name:	 	Kirk R. Oliver
	Title:	 	Senior Vice President and Chief Financial Officer

 [Signature Page to Purchase Agreement] 

 Accepted: As of the date first written above 

BARCLAYS CAPITAL INC. 
 For itself and on behalf of the 

several Initial Purchasers listed 
 in Schedule 1 hereto. 

			
		
	By	 	 /s/ William Nelson Mabry

		 	Authorized Signatory

 [Signature Page to Purchase Agreement] 

 Schedule 1 
  

									
	 	  	2029 Notes	 	  	2031 Notes	 
	 Initial Purchaser
	  	Principal Amount	 	  	Principal Amount	 
	 Barclays Capital Inc.
	  	$	160,000,000	 	  	$	220,000,000	 
	 BofA Securities, Inc.
	  	$	96,000,000	 	  	$	132,000,000	 
	 J.P. Morgan Securities LLC
	  	$	96,000,000	 	  	$	132,000,000	 
	 Citigroup Global Markets Inc.
	  	$	52,000,000	 	  	$	71,500,000	 
	 MUFG Securities Americas Inc.
	  	$	52,000,000	 	  	$	71,500,000	 
	 PNC Capital Markets LLC
	  	$	52,000,000	 	  	$	71,500,000	 
	 Scotia Capital (USA) Inc.
	  	$	52,000,000	 	  	$	71,500,000	 
	 TD Securities (USA) LLC
	  	$	52,000,000	 	  	$	71,500,000	 
	 Wells Fargo Securities, LLC
	  	$	52,000,000	 	  	$	71,500,000	 
	 Credit Suisse Securities (USA) LLC
	  	$	30,000,000	 	  	$	41,250,000	 
	 Deutsche Bank Securities Inc.
	  	$	30,000,000	 	  	$	41,250,000	 
	 SMBC Nikko Securities America, Inc.
	  	$	30,000,000	 	  	$	41,250,000	 
	 U.S. Bancorp Investments, Inc.
	  	$	30,000,000	 	  	$	41,250,000	 
	 CIBC World Markets Corp.
	  	$	8,000,000	 	  	$	11,000,000	 
	 Truist Securities, Inc.
	  	$	8,000,000	 	  	$	11,000,000	 
		  	  
	  
	 	  	  
	  
	 
	 Total
	  	$	800,000,000	 	  	$	1,100,000,000	 

 Schedule 2 
  

			
	 Entity
	  	Jurisdiction
	 Equitrans Investments, LLC
	  	Delaware
	 Equitrans Services, LLC
	  	Delaware
	 Equitrans, L.P.
	  	Pennsylvania
	 Equitrans Transaction Sub GP, LLC
	  	Delaware
	 Equitrans Water Services (PA), LLC
	  	Delaware
	 Equitrans Water Services (OH), LLC
	  	Delaware
	 EQGP Holdings, LP
	  	Delaware
	 EQM Midstream Finance Corporation
	  	Delaware
	 EQM Midstream Management LLC
	  	Delaware
	 EQM Midstream Services, LLC
	  	Delaware
	 EQM Gathering Holdings, LLC
	  	Delaware
	 EQM Gathering Opco, LLC
	  	Delaware
	 EQM Olympus Midstream LLC
	  	Delaware
	 EQM Poseidon Midstream LLC
	  	Delaware
	 EQM West Virginia Midstream LLC
	  	Delaware
	 EQM VE II Access, LLC
	  	Delaware
	 EQM VG, LLC
	  	Delaware
	 Hornet Midstream Holdings, LLC
	  	Delaware
	 Hornet Midstream Pipeline, LLC
	  	Delaware
	 MVP Holdco, LLC
	  	Delaware
	 Rager Mountain Storage Company LLC
	  	Delaware
	 RM Partners LP
	  	Delaware
	 RM Operating LLC
	  	Delaware
	 Strike Force Midstream Holdings LLC
	  	Delaware
	 Strike Force Midstream LLC
	  	Delaware
	 Strike Force East LLC
	  	Delaware
	 Strike Force South LLC
	  	Delaware

 ANNEX A 

Additional Time of Sale Information 

1.    Term sheet containing the terms of the Securities, substantially in the form of Annex B. 

 ANNEX B 

Pricing Term Sheet 

[See attached] 

 Pricing Term Sheet, dated January 4, 2021 

to Preliminary Offering Memorandum dated January 4, 2021 

Strictly Confidential 

EQM Midstream Partners, LP 
 This pricing
term sheet is qualified in its entirety by reference to the Preliminary Offering Memorandum dated January 4, 2021 (the “Preliminary Offering Memorandum”). The information in this pricing term sheet supplements the Preliminary Offering
Memorandum and updates and supersedes the information in the Preliminary Offering Memorandum to the extent it is inconsistent with the information in the Preliminary Offering Memorandum. Terms used and not defined herein have the meanings assigned
in the Preliminary Offering Memorandum. 
 The notes have not been and will not be registered under the Securities Act of 1933, as amended (the
“Securities Act”), or the securities laws of any other jurisdiction. The notes may not be offered or sold in the United States or to U.S. persons (as defined in Regulation S) except in transactions exempt from, or not subject to, the
registration requirements of the Securities Act. Accordingly, the notes are being offered only to (1) persons reasonably believed to be “qualified institutional buyers” as defined in Rule 144A under the Securities Act and
(2) outside the United States to non-U.S. persons in compliance with Regulation S under the Securities Act. 
  

					
	Issuer:	  	EQM Midstream Partners, LP	  	
	Distribution:	  	Rule 144A and Regulation S for life (no registration rights)
			
	 	  	 4.50% Senior Notes due 2029
	  	 4.75% Senior Notes due 2031

	 	  	 (the “2029 Notes”)
	  	 (the “2031 Notes”)

	Security Description:	  	4.50% Senior Notes due 2029	  	4.75% Senior Notes due 2031
	Size:	  	$800,000,000	  	$1,100,000,000
	Gross Proceeds:	  	$800,000,000	  	$1,100,000,000
	Maturity:	  	January 15, 2029	  	January 15, 2031
	Coupon:	  	4.50%	  	4.75%
	Issue Price:	  	100.00% of face amount	  	100.00% of face amount
	Yield to Maturity:	  	4.50%	  	4.75%
	Spread to Benchmark Treasury:	  	+375 basis points	  	+388 basis points
	Benchmark Treasury:	  	UST 2.625% due February 15, 2029	  	UST 5.375% due February 15, 2031
	Interest Payment Dates:	  	January 15 and July 15 commencing July 15, 2021	  	January 15 and July 15 commencing July 15, 2021
	Record Dates:	  	January 1 and July 1	  	January 1 and July 1
	Optional Redemption:	  	Make-whole call @ T+50 bps prior to July 15, 2028 (the “2029 Par Call Date”). On and after the 2029 Par Call Date, at a redemption price equal to 100% of the principal amount of the 2029 Notes being redeemed plus accrued
and unpaid interest.	  	Make-whole call @ T+50 bps prior to July 15, 2030 (the “2031 Par Call Date”). On and after the 2031 Par Call Date, at a redemption price equal to 100% of the principal amount of the 2031 Notes being redeemed plus accrued
and unpaid interest.
	 Change of Control (with Ratings

Downgrade):
	  	 Put at 101% of the aggregate principal
 amount
of the 2029 Notes, plus
 accrued and unpaid interest.
	  	 Put at 101% of the aggregate principal
 amount
of the 2031 Notes, plus
 accrued and unpaid interest.

	 CUSIP:
	  	 144A: 26885BAK6
 REG S: U26886AC2
	  	 144A: 26885BAL4
 REG S: U26886AD0

	 ISIN:
	  	 144A: US26885BAK61
 REG S: USU26886AC29
	  	 144A: US26885BAL45
 REG S:
USU26886AD02

			
	Trade Date:	  	January 4, 2021
	Settlement:	  	T+4; January 8, 2021
		  	  
 The Company expects to deliver the Notes against payment for the
Notes on or about the date specified on the cover page of the Preliminary Offering Memorandum, which will be the fourth business day following the date of the pricing of the Notes (such settlement cycle being referred to as “T+4”). Under
Rule 15c6-1 under the Exchange Act, trades in the secondary market generally are required to settle in two business days unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers
who wish to trade the Notes on any date prior to the second business day before delivery thereof will be required, by virtue of the fact that the Notes initially will settle in T+4, to specify an alternative settlement cycle at the time of any such
trade to prevent failed settlement. Purchasers of the Notes who wish to trade the Notes prior to the second business day before their delivery should consult their own advisors.

	Denominations/Multiple:	  	$2,000 x $1,000
	 Ratings*:
	  	 Ba3 (negative outlook, Moody’s)
 BB- (stable outlook, S&P)
 BB (negative outlook, Fitch)

	 Joint Book-Running Managers:
	  	 Barclays Capital Inc
 BofA Securities,
Inc.
 J.P. Morgan Securities LLC
 Citigroup Global Markets
Inc.
 MUFG Securities Americas Inc.
 PNC Capital Markets
LLC
 Scotia Capital (USA) Inc.
 TD Securities (USA) LLC

Wells Fargo Securities, LLC
 Credit Suisse Securities (USA)
LLC
 Deutsche Bank Securities Inc.

	 Senior Co-Managers:
	  	 SMBC Nikko Securities America, Inc.
 U.S.
Bancorp Investments, Inc.

	 Co-Managers:
	  	 CIBC World Markets Corp.
 Truist Securities,
Inc.

 Changes from Preliminary Offering Memorandum 

The Preliminary Offering Memorandum is hereby updated to reflect the following changes: 

The total size of the offering has increased from $1,750,000,000 to $1,900,000,000. The net proceeds from the offering will be approximately
$1,876.5 million, after deducting the initial purchasers’ discount and estimated offering expenses. As a result of the change in offering size, all information (including financial information) presented in the Preliminary Offering
Memorandum is deemed to have changed to the extent affected by the changes described herein. 
 In connection with the offering of the Notes, the Company
has amended the Tender Offers to increase the Aggregate Maximum Principal Amount from $350,000,000 to $500,000,000 for all of the notes validly tendered and not validly withdrawn pursuant to the Tender Offers. All references in the Preliminary
Offering Memorandum to the Aggregate Maximum Principal Amount are hereby updated to $500,000,000. 

 As a result of the amended Tender Offers relating to the increase in the Aggregate Maximum Principal Amount,
the outstanding principal amount of Existing Senior Notes in the “As adjusted (unaudited)” column in the “Capitalization” section of the Preliminary Offering Memorandum are hereby updated from $4,750,000 to $4,600,000. 

***** 
 This material is confidential and is
for your information only and is not intended to be used by anyone other than you. This information does not purport to be a complete description of these notes or the offering. Please refer to the Preliminary Offering Memorandum for a complete
description. 
 This communication is being distributed in the United States solely to persons reasonably believed to be Qualified Institutional
Buyers, as defined in Rule 144A under the Securities Act of 1933, as amended, and outside the United States solely to Non-U.S. persons as defined under Regulation S. 

This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction to any person to whom it
is unlawful to make such offer or solicitation in such jurisdiction. 
  

	*A	 securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or
withdrawal at any time. 

 Any disclaimer or other notice that may appear below is not applicable to this communication and should be
disregarded. Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg or another email system. 

 ANNEX C 

Restrictions on Offers and Sales Outside the United States 

In connection with offers and sales of Securities outside the United States: 

(a)    Each Initial Purchaser acknowledges that the Securities have not been registered under the Securities Act and may
not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons except pursuant to an exemption from, or in transactions not subject to, the registration requirements of the Securities Act. 

(b)    Each Initial Purchaser, severally and not jointly, represents, warrants and agrees that: 

(i)    Such Initial Purchaser has offered and sold the Securities, and will offer and sell the Securities,
(A) as part of their distribution at any time and (B) otherwise until 40 days after the later of the commencement of the offering of the Securities and the Closing Date, only in accordance with Regulation S under the Securities Act
(“Regulation S”) or Rule 144A or any other available exemption from registration under the Securities Act. 

(ii)    None of such Initial Purchaser or any of its affiliates or any other person acting on its or their
behalf has engaged or will engage in any directed selling efforts with respect to the Securities, and all such persons have complied and will comply with the offering restrictions requirement of Regulation S. 

(iii)    At or prior to the confirmation of sale of any Securities sold in reliance on Regulation S, such
Initial Purchaser will have sent to each distributor, dealer or other person receiving a selling concession, fee or other remuneration that purchases Securities from it during the distribution compliance period a confirmation or notice to
substantially the following effect: 
 The Securities covered hereby have not been registered under the U.S. Securities Act of 1933, as
amended (the “Securities Act”), and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons (i) as part of their distribution at any time or (ii) otherwise until 40 days
after the later of the commencement of the offering of the Securities and the date of original issuance of the Securities, except in accordance with Regulation S or Rule 144A or any other available exemption from registration under the Securities
Act. Terms used above have the meanings given to them by Regulation S. 

 (iv)    Such Initial Purchaser has not and will not
enter into any contractual arrangement with any distributor with respect to the distribution of the Securities, except with its affiliates or with the prior written consent of the Partnership. 

Terms used in paragraph (a) and this paragraph (b) and not otherwise defined in this Agreement have the meanings given to them by Regulation S.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}]]